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ABSTRACT 
 
ROLES OF TNFAIP8 PROTEIN IN CELL DEATH, LISTERIOSIS, AND COLITIS 
 
Thomas P. Porturas 
 
Youhai H. Chen 
 
TNFα-induced protein 8 (TNFAIP8 or TIPE) is a newly described regulator of cancer and 
infection. However, its precise roles and mechanisms of actions are not well understood. Here I 
report the generation of TNFAIP8 knockout mice and describe their increased responsiveness to 
colonic inflammation and resistance to lethal Listeria monocytogenes infection. TNFAIP8 
knockout mice were generated by germ line gene targeting and were born without noticeable 
developmental abnormalities. Their major organs including those of the immune and digestive 
systems were macroscopically and microscopically normal. However, compared to wild type 
mice, TNFAIP8 knockout mice exhibited significant differences in the development of listeriosis 
and experimentally induced colitis. I discovered that TNFAIP8 regulates L. monocytogenes 
infection by controlling pathogen invasion and host cell apoptosis potentially in a RAC1 GTPase-
dependent manner. TNFAIP8 knockout mice had reduced bacterial load in the liver and spleen 
and TNFAIP8 knockdown in murine liver HEPA1-6 cells increased apoptosis, reduced bacterial 
invasion into cells, and resulted in dysregulated RAC1 activation. The combined effect of reduced 
bacterial invasion and increased sensitivity to TNFα-induced clearance likely protected the 
TNFAIP8 knockout mice from lethal listeriosis. On the other hand, I also discovered that the 
increased apoptosis sensitized TNFAIP8 knockout mice to dextran sodium sulfate-induced colitis 
as demonstrated by decreased survival rates and increased body weight loss of TNFAIP8 
knockout mice, and enhanced leukocyte infiltration, bacterial invasion, and inflammatory cytokine 
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production in the TNFAIP8 knockout colon. Bone marrow chimeric experiments revealed that 
TNFAIP8 deficiency in non-hematopoietic cells was responsible for the exacerbated colitis and 
resistance to listeriosis in TNFAIP8 knockout mice. Taken together, these findings indicate that 
TNFAIP8 plays an important role in maintaining colon homeostasis, protecting against colitis, and 
regulating the pathogenesis of L. monocytogenes infection by controlling bacterial invasion and/or 
cell death of the non-immune cells. 
 v 
Table of Contents 
 
ACKNOWLEDGMENT .................................................................................................................... II 
ABSTRACT .................................................................................................................................... III 
LIST OF FIGURES ....................................................................................................................... VIII 
CHAPTER 1 – INTRODUCTION ..................................................................................................... 1 
1.1 INFLAMMATION ......................................................................................................................... 1 
1.2 INFLAMMATION AND CANCER ..................................................................................................... 3 
1.3 TNFAIP8 IS A NOVEL ONCOGENE .............................................................................................. 4 
1.4 TNFAIP8 FAMILY ..................................................................................................................... 5 
1.5 TIPE2 IN INFLAMMATION ........................................................................................................... 7 
1.6 GOALS OF THIS RESEARCH PROJECT ......................................................................................... 8 
CHAPTER 2 – MATERIALS AND METHODS .............................................................................. 10 
2.1 ANIMALS ................................................................................................................................ 10 
2.2 GENERATION AND GENOTYPING OF TNFAIP8-/- MICE ................................................................. 10 
2.3 PHENOTYPING OF TNFAIP8-/- MICE ........................................................................................... 12 
2.4 BONE MARROW CHIMERAS ...................................................................................................... 12 
2.5 RT-PCR................................................................................................................................ 12 
2.6 CELL LINES AND PLASMIDS ...................................................................................................... 13 
2.7 PLASMID DNA TRANSFECTION AND VIRAL INFECTION ................................................................ 13 
2.8 MICROBIAL STRAINS AND INFECTION ........................................................................................ 14 
2.9 DSS-INDUCED COLITIS ........................................................................................................... 15 
2.10 DETERMINATION OF CLINICAL SCORES ................................................................................... 15 
2.11 HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY .................................................................. 15 
2.12 ISOLATION OF COLON EPITHELIAL CELLS ................................................................................ 16 
 vi 
2.13 COLON LEUKOCYTES ISOLATION ............................................................................................ 16 
2.14 BLOOD CELL COUNTS ........................................................................................................... 16 
2.15 BACTERIAL CULTURE ............................................................................................................ 17 
2.16 MACROPHAGE AND NEUTROPHIL PREPARATIONS .................................................................... 17 
2.17 PHAGOCYTOSIS ASSAY. ........................................................................................................ 18 
2.18 CHEMOTAXIS ASSAY ............................................................................................................. 19 
2.19 ELISA ................................................................................................................................. 19 
2.20 CELL DEATH AND PROLIFERATION .......................................................................................... 19 
2.21 TNFΑ STIMULATION .............................................................................................................. 20 
2.22 WESTERN BLOT .................................................................................................................... 20 
2.23 IMMUNOPRECIPITATION ......................................................................................................... 21 
2.24 LOADING OF RAC1 WITH GDP AND GTP .............................................................................. 21 
2.25 PAK PULL-DOWN ASSAY...................................................................................................... 22 
2.26 STATISTICAL ANALYSIS ......................................................................................................... 22 
CHAPTER 3 – LISTERIOSIS ........................................................................................................ 23 
3.1 INTRODUCTION ....................................................................................................................... 23 
3.2 RESULTS ............................................................................................................................... 25 
3.2.1 TNFAIP8 knockout mice are resistant to lethal Listeria monocytogenes infection ...... 25 
3.2.2 TNFAIP8 deficiency does not protect mice from Staphylococcus aureus infection ..... 29 
3.2.3 No difference in immune cell function in Tnfaip8-/- mice .............................................. 31 
3.2.4 Non-hematopoietic cells may be responsible for resistance to lethal infection ............ 34 
3.3 DISCUSSION ........................................................................................................................... 37 
CHAPTER 4 – EXPERIMENTAL COLITIS ................................................................................... 40 
4.1 INTRODUCTION ....................................................................................................................... 40 
4.2 RESULTS ............................................................................................................................... 42 
4.2.1 Tnfaip8-/- mice are hyper-sensitive to DSS-induced colitis ........................................... 42 
 vii 
4.2.2 Enhanced inflammatory response in Tnfaip8-/- mice with colitis .................................. 45 
4.2.3 TNFAIP8-deficiency in non-hematopoietic cells exacerbates colitis ............................ 51 
4.2.4 Reduced epithelial integrity and increased bacterial infection in Tnfaip8-/- mice ......... 54 
4.3 DISCUSSION ........................................................................................................................... 57 
CHAPTER 5 – CELL DEATH AND INFECTION .......................................................................... 60 
5.1 INTRODUCTION ....................................................................................................................... 60 
5.2 RESULTS ............................................................................................................................... 62 
5.2.1 TNFAIP8 knockdown cells are sensitized to cell death ............................................... 62 
5.2.2 TNFAIP8 knockdown cells are sensitized to infection and death by L. monocytogenes
 ............................................................................................................................................... 66 
5.2.3 TNFAIP8 associates with RAC1 with a higher affinity towards active RAC1-GTP in 
vitro. ....................................................................................................................................... 68 
5.2.4 TNFAIP8 affects RAC1 activity .................................................................................... 71 
5.3 DISCUSSION ........................................................................................................................... 76 
CHAPTER 6 – DISCUSSION AND FUTURE DIRECTIONS ........................................................ 81 
CHAPTER 7 – PUBLICATIONS .................................................................................................... 90 
7.1 CRUCIAL ROLES OF TNFΑIP8 PROTEIN IN REGULATING APOPTOSIS AND LISTERIA INFECTION. .... 90 
7.2 EXACERBATED EXPERIMENTAL COLITIS IN TNFAIP8-DEFICIENT MICE. ..................................... 91 
7.3 CRITICAL ROLES OF TIPE2 PROTEIN IN MURINE EXPERIMENTAL COLITIS. ................................... 92 
CHAPTER 8 – REFERENCES ...................................................................................................... 93 
 
 viii 
LIST OF FIGURES 
Figure 1. TNFAIP8 family sequence alignment ............................................................................... 6 
Figure 2. Generation of Tnfaip8-knockout mice by gene targeting ................................................ 11 
Figure 3. L Monocytogenes infection in Tnfaip8-/- mice ................................................................. 26 
Figure 4. Liver and spleen bacterial load and damage .................................................................. 27 
Figure 5. No statistical difference in TNFα and IL-6 in infected mice ............................................ 28 
Figure 6. No difference in S. aureus infection ................................................................................ 30 
Figure 7. No difference chemotaxis or phagocytosis ..................................................................... 32 
Figure 8. No difference in TNFα and IL-6 production .................................................................... 33 
Figure 9. Generation of bone marrow chimeric mice ..................................................................... 35 
Figure 10. Replacing Tnfaip8-/- bone marrow with wild type does not ablate resistance to lethal L. 
monocytogenes infection ............................................................................................................... 36 
Figure 11. Tnfaip8-/- mice are hyper-sensitive to DSS-induced colitis ........................................... 43 
Figure 12. Tnfaip8-/- colons are more inflamed .............................................................................. 44 
Figure 13. Increased leukocyte mobilization in Tnfaip8-/- mice. ..................................................... 46 
Figure 14. Increased myeloid and B-cell infiltration in Tnfaip8-/- colon .......................................... 47 
Figure 15. No difference in leukocyte numbers in untreated mice ................................................ 48 
Figure 16. Dexamethasone-induced cell death was not affected in Tnfaip8-/- thymocytes ........... 49 
Figure 17. Increased inflammatory cytokines in serum and colon of Tnfaip8-/- mice ..................... 50 
Figure 18. TNFAIP8 deficiency in non-hematopoietic cells contributes to the enhanced colitis in 
knockout mice ................................................................................................................................ 52 
Figure 19. TNFAIP8 in gut epithelial cell death and proliferation .................................................. 55 
Figure 20. Increased bacterial invasion in Tnfaip8-/- colons........................................................... 56 
Figure 21. Hepa1-6 and NIH3T3 TNFAIP8 knockdowns ............................................................... 63 
Figure 22. Knockdown cells are sensitized to cell death ............................................................... 64 
Figure 23. Minor difference in proliferation of knockdown cells ..................................................... 65 
 ix 
Figure 24. Listeria infection was reduced in TNFAIP8 knockdown cells and cell death was 
increased ........................................................................................................................................ 67 
Figure 25. Overexpressed TNFAIP8 associates with RAC1 ......................................................... 69 
Figure 26.TNFAIP8 has a stronger association with GTPγS loaded RAC1 .................................. 70 
Figure 27. Impaired RAC1 activation in TNFAIP8 knockdown cells .............................................. 73 
Figure 28. RAC1 mutants did not rescue cell death in TNFAIP8 knockdown cells ....................... 74 
Figure 29. RAC1 inhibition reduced bacterial infection .................................................................. 75 
Figure 30. TNFAIP8 project summary ........................................................................................... 86 
Figure 31. Model of TNFAIP8 molecular function in cell death ..................................................... 87 
Figure 32. Model of RAC1 molecular function during Listerial cell invasion .................................. 88 
Figure 33. Model of TNFAIP8 role in host cell invasion by L. monocytogeneses ......................... 89 
 1 
CHAPTER 1 – Introduction 
 
1.1 Inflammation 
 
 Inflammation is a broad term used to describe the body’s biochemical and cellular 
responses to injury. Regulation of this response is critically important in maintaining a healthy 
homeostasis while simultaneously sustaining the capacity to protect the organism from foreign 
agents and injury. There are many potential inducers of inflammation, ranging from microbial 
pathogens to the diet of the organism. Deregulation of the inflammatory response can lead to a 
wide variety of diseases that include autoimmune diseases, susceptibility to certain pathogens, 
and even an increased risk of cancer. 
The normal response to tissue injury involves the release of pro-inflammatory molecules 
such as TNFα, IL-1, and IL-6 that activate local leukocytes such as resident mast cells and 
macrophages that further continue a signaling cascade by releasing histamines that promote 
blood flow, and chemokines such as IL-8 that attract additional leukocytes to the region 
(Medzhitov 2008). The leukocytes, primarily neutrophils and antigen presenting cells, attempt to 
identify pathogenic agents and clear the site of foreign particles and cell debris to clean the 
wound. If a pathogen is detected, an additional cascade of pro-inflammatory cytokines is released 
to promote the recruitment of additional phagocytes and the activation of the adaptive immune 
response through the antigen presenting cells. After the clearance of any pathogens and foreign 
or cellular debris, anti-inflammatory molecules are released such as IL-4, IL-10, and IL-13 and 
growth factors such as TGFβ, PDGF, and VEGF from the leukocytes to encourage tissue 
regeneration and immune suppression (Laskin 2009). After healing is completed, the tissue is 
restored to homeostasis, and blood flow and leukocyte infiltration is restored to normal. 
If the inflammatory response is not resolved, chronic inflammation may persist and cause 
additional injury. As the immune system attempts to fight off a pathogen, inflammatory molecules 
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such as cytokines, reactive oxygen species, and apoptotic inducing molecules such as TNFα are 
released that cause collateral damage within the tissue. This damage may feed back into the 
inflammatory response creating a persistent cycle of inflammation. This chronic inflammation can 
be very toxic to the infected organs such as with Hepatitis B and C, which may result in cirrhosis, 
liver failure and cancer (Caccamo et al. 2014). An exaggerated response may be just as 
dangerous and may range from mild allergic reactions against external antigens to the often fatal 
septic shock from overwhelming stimulation of the immune system (Pravda 2014). Besides a 
persistent chronic or overwhelming infection and response, the immune system may mistakenly 
target a self-antigen, resulting in an autoimmunity disorder that cannot resolve itself. Autoimmune 
diseases such as rheumatoid arthritis and inflammatory bowel diseases may be very debilitating 
and even result in death if untreated as with type 1 diabetes, systemic lupus erythematosus, and 
multiple sclerosis (Cooper & Stroehla 2003). In addition, the tissue damage resulting from the 
inflammation can result in genetic instability and promote tumorigenesis. 
While too much inflammation may be problematic, a weak response may predispose an 
organism to infection. The inflammatory environment is very toxic and hostile to pathogens, and 
therefore pathogenic microorganisms tend to devote significant resources in evading the host 
immune system. A dulled immune response will, however, allow pathogens free reign over the 
host tissue that can lead to necrotic cell death and tissue destruction. Even a slightly impaired 
response may be enough to allow a pathogen to escape the site of injury and gain wider access 
to the other organs that can lead to sepsis and fatal systemic infection. Immune deficiencies may 
result from the lack of cellular components such as B cells, T cells, or neutrophils, and a lack of 
molecular components such as complement proteins or inflammatory cytokines. Each of these 
deficiencies is associated with a predisposition to certain pathogens that are controlled by that 
particular aspect of the immune system. A B cell deficiency, for instance, will result in a lack of 
humoral immunity and predispose the host to certain extracellular pathogens such as 
Streptococcus pneumonia, while a T-cell deficiency will result in susceptibility to intracellular 
pathogens such as Listeria monocytogenes (Bannister et al. 2009).There are many causes of 
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immunodeficiency such as genetic mutations, immune suppressive drugs, chemotherapy, and 
HIV infection. The regulation of inflammation is therefore important to making sure the response 
is sufficient to clear an infection but to keep it under control so as not to cause chronic 
inflammation or fatal septic shock. 
 
1.2 Inflammation and cancer 
 
 Cancer is highly intertwined with inflammation. Tumorigenesis involves tissue injury and 
necrotic cell death along with the exposure of antigens typically not expressed by normal cells. 
These events signal the immune system to promote inflammation. The inflammatory response 
can have two very contrasting effects on the tumor, destroy it and lead to remission or promote 
vascularization, metastasis, and its growth. Therefore, understanding inflammation is crucial to 
gaining insight on cancer development and treatment. 
 Chronic inflammation results in the release of reactive oxygen species and the cyclical 
destruction and proliferation of tissue that promotes genetic damage, which is the first step to 
tumor development. Following the escape from cell cycle control, new cancer cells are able to 
take advantage of released growth factors and inflammatory cytokines such as TNFα to activate 
molecular survival and proliferation pathways (de Visser et al. 2006). The continued inflammation 
may accelerate genomic instability through the production of reactive oxygen species, promote 
angiogenesis to provide blood flow to the developing tumor, and even interfere with immune 
surveillance that may help fight the cancer. This inflammatory tumor microenvironment exists 
around most tumors, and while the inflammation is often harmful and ineffective at protecting the 
host, it is still important in finally clearing the cancer.  
 The immune system is constantly surveying tissues for not just harmful pathogens and 
debris, but also for potentially malignant cells. Important cells include natural killer (NK) cells that 
detect and eliminate distressed cells based on altered surface receptor expression, dendritic cells 
and macrophages that respond to danger signals and detect and present antigens that are not 
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normally produced to the adaptive immune system, and cytotoxic T lymphocytes (CTLs) that 
when activated can target these specific antigens on the cancer cells (Grivennikov et al. 2010). 
This antitumor response can be inhibited and suppressed by regulatory T cells inhibiting CTLs, 
and macrophages and neutrophils limiting access to antitumor lymphocytes. A balance may exist 
between pro and anti-tumor effects from the immune system that if pushed one way can lead to 
an aggressive cancer and tumor elimination in the other. Macrophages, for example, can be 
activated into two distinct functional phenotypes, the pro-inflammatory M1 macrophages that 
contribute to tumor cell killing and autoimmune diseases, and anti-inflammatory M2 macrophages 
that can suppress the immune response and promote angiogenesis, proliferation and 
extracellular remodeling that can contribute to tumor growth and development (Hao et al. 2012). 
Therefore, one of the biggest challenges in cancer therapy is to find ways to modulate the 
immune system using drugs, adoptive cell therapies, and antibody treatments to destroy cancer 
cells (Hegmans & Aerts 2014). To develop these novel therapies, a more thorough understanding 
of both cancer and inflammation is necessary and precisely how these two processes are linked. 
 
1.3 TNFAIP8 is a novel oncogene 
 
Tumor necrosis factor α-induced protein 8 (TNFΑIP8 or TIPE), also known as SCC-S2, 
OXI-α, GG2-1, NDED, and MDC-3.13, is the first described member of the TNFΑIP8 family. It is 
an NF-κB inducible protein upregulated in metastatic head and neck squamous cell carcinoma 
cell lines and it has been found to protect cancer cells against TNFα-induced apoptosis (Patel et 
al. 1997; Kumar et al. 2000). By contrast, TNFAIP8 may promote glucocorticoid-induced 
apoptosis of normal thymocytes in culture (Woodward et al. 2010). Overexpression in tumor cell 
lines also enhanced proliferation and migration (Kumar et al. 2004). Activated Gαi3 and 
Karyopherin α2 in PC-3 cells have been identified as potential TNFAIP8 interacting partners to 
regulating cell death and transformation (Laliberté et al. 2010). TNFAIP8 may not only be 
involved in disease pathogenesis, but also serve as a novel biomarker for certain inflammatory 
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diseases and cancers. TNFAIP8 gene polymorphisms and expression are associated with non-
Hodgkin’s lymphoma, ovarian, cervical and prostate cancers, psoriasis, and with susceptibility to 
Staphylococcus aureus infection in mice (Ahn et al. 2010; Liu et al. 2013; Romanuik et al. 2009; 
Shi et al. 2013; Filkor et al. 2013; Zhang, Wang, et al. 2012). However, the precise roles of 
TNFAIP8 in health and disease remain to be established. 
 
1.4 TNFAIP8 family 
 
 TNFAIP8 is the first member discovered of the novel TNFAIP8 family of proteins. 
TNFAIP8-Like 1 (TIPE1), TNFAIP8-Like 2 (TIPE2), and TNFAIP8-Like 3 (TIPE3) are the other 
known members and they all share very high amino acid sequence homology to TNFAIP8 (Figure 
1). This family of proteins have a very unique structure besides a death effector domain (DED) 
like sequence, but the crystal structure of TIPE2 revealed this to be a unique fold among DED 
containing proteins encompassing the entire protein sequence (Lou & Liu 2011; Zhang et al. 
2009). TNFAIP8 and TIPE1 are both widely expressed throughout a variety of tissues except for 
TIPE1 being undetectable in mature lymphocytes (Kumar et al. 2000; Cui et al. 2011). TIPE3 is 
found predominantly in non-lymphoid tissues while TIPE2 expression is localized to immune cells 
(Fayngerts et al. 2014; Sun et al. 2008). TIPE1 down-regulation is correlated with worse 
prognosis for cancer patients and it has been shown to promote cell death by inhibiting the RAC1 
pathway (Z. Zhang et al. 2014). In addition, TIPE1 has found to positively regulate autophagy in a 
neural cell line model of Parkinson’s disease (Ha et al. 2014). TIPE2, like TIPE1, has also been 
shown to have antitumor functionality, and it has been identified as a key negative regulator of 
inflammation (Y. H. Zhang et al. 2014; Cao et al. 2013; Sun et al. 2008). TIPE3 has only been 
recently characterized and has been shown to promote tumorigenesis through the regulation of 
phosphoinositide signals (Fayngerts et al. 2014). All of the members of TNFAIP8 family are 
involved in tumorigenesis and cell death, and investigating this family may prove crucial to our 
understanding and treatment of cancer.
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Figure 1. TNFAIP8 family sequence alignment 
The TNFAIP8 family shows high homology in its amino acid sequence with a BLOSUM62 score 
of 15372 and 54% identity. Alignment was calculated by Clustal Omega and PRALINE multiple 
sequence alignment tools. The image was generated using Jalview. 
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1.5 TIPE2 in inflammation 
 
TIPE2 is the second most well known member of the TNFAIP8 family.  It was discovered 
in a mouse model for multiple sclerosis by comparing the gene expression profiles of spinal cord 
tissue from healthy mice with that of mice with induced experimental autoimmune 
encephalomyelitis (EAE).  The inflamed EAE spinal cord tissue expressed large amounts of 
TIPE2, drawing interest in the gene for further study that eventually resulted in the development 
of a TIPE2 knockout mouse via germ line gene targeting (Sun et al. 2008). TIPE2 deficient mice 
develop normally but are prone to many debilitating inflammatory diseases that are characterized 
by heightened inflammatory cytokine production, sensitivity to septic shock, and premature death. 
These mice had abnormally high levels of circulating cytokines, and had a larger number of both 
lymphocytes and monocytes, resulting in significant splenomegaly. In inflammatory diseases, 
TIPE2 is down-regulated in peripheral blood mononuclear cells in patients suffering from lupus 
and hepatitis, and it is upregulated in kidneys of diabetic rats (Li et al. 2009; Xi et al. 2011; Zhang 
et al. 2010).  Additionally, recently published work has indicated that TIPE2 may provide a 
protective function against ischemia/reperfusion injury following a stroke (Zhang, Wei, et al. 
2012). 
TIPE2 is normally expressed at high levels in all immune cells and shows inducible 
expression in fibroblast cell lines (Sun et al. 2008).  The loss of TIPE2 correlates with increased 
levels of IκB degradation and increased nuclear localization of NF-κB family members. In TIPE2 
overexpression, levels of NF-κB activity in response to TNFα treatment were reduced. TIPE2 
knockdown also resulted in increased phospho-JNK, phospho-p38, and c-Fos signaling. TIPE2 
can associate endogenously with caspase 8 in macrophage cell lines and caspase 8 has been 
previously shown to activate NF-kB through a BCL10 / MALT1 complex (Su et al. 2005).  
Knockdown of TIPE2 in EL4 T Cells resulted in resistance to FasL induced cell death, while 
TIPE2 knockout T Cells are resistant to activation induced cell death. TIPE2 knockout T cells 
develop normally but produce more tetramer positive CD8+ T cells in response to LCMV infection 
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and produce more cytokines following CD3/CD28 stimulation. TIPE2 knockout macrophages also 
produce more cytokines when exposed to TLR ligands. TIPE2 has recently been shown to bind to 
and inhibit the small GTPase Rac1 resulting in inhibition of phagocytosis in macrophages (Wang 
et al. 2012). This modulation of the immune system is important during bacterial infections since 
TIPE2 knockout mice have been shown to be resistant against Listeria monocytogenes and 
Staphylococcus aureus infection. 
 The regulatory role on inflammation by TIPE2 has also been found to be linked to cancer. 
TIPE2 is an inhibitor of the oncogenic GTPase Ras signaling pathway and has been shown to 
associate with RGL, an activator of RalA and RalB (Gus-Brautbar et al. 2012). TIPE2 regulates 
cell migration, exocyst assembly, and Actin dynamics in vitro, and its overexpression inhibited 
Ras-induced transformation in NIH3T3 cells. Due to the crucial function of TIPE2 in the immune 
system, inflammation and cancer, and its high homology with TNFAIP8, many functional roles 
and molecular pathways of TIPE2 may be shared with TNFAIP8. The recently published roles of 
TIPE2 may reveal the functional roles of TNFAIP8 and shed light on how TNFAIP8 is important to 
both inflammation and cancer. 
 
1.6 Goals of this research project 
 
The current published works on TNFAIP8 have labeled it as an oncogene, and few have 
attempted to identify its role outside of the cancer field. Due to the importance of inflammation for 
tumorigenesis and our lab’s published results suggesting that TIPE2 is a critical regulator of 
inflammation, we began to investigate the roles of TNFAIP8 in inflammation. It is important to 
note that while TIPE2 is expression is localized to immune cells, TNFAIP8 is widely expressed 
throughout the body, suggesting a potentially larger impact of gene dysfunction affecting both 
immune and non-immune cells. Using TNFAIP8 knockout mice, we planned to identify the normal 
physiological roles of TNFAIP8 in two different models of inflammation, bacterial infection and 
experimental colitis. After identifying a phenotype, we further investigated the cellular and 
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molecular role of TNFAIP8 to develop a model that may explain the importance of TNFAIP8 to a 
wider variety of diseases. 
Our overarching hypothesis is that TNFAIP8 regulates inflammation, and this regulation 
is critical to modulating a variety of diseases. I developed three specific aims to test this 
hypothesis. The first is to test whether TNFAIP8 affects the outcome of Listeria monocytogenes 
infection in TNFAIP8 knockout mice. The second aim is to determine whether induced 
experimental colitis is affected by TNFAIP8 deficiency in mice. The third aim is to identify the 
cellular and molecular role of TNFAIP8 deficiency in knockdown cell models.  
 This study is one of few that intends to investigate the importance of TNFAIP8 outside of 
the field of cancer. The information learned may be crucial to understanding a wide variety of 
inflammatory diseases in addition to gaining a better understanding of how TNFAIP8 is involved 
in cancer. This understanding may eventually lead to novel medical treatment methods and 
diagnostic procedures. 
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CHAPTER 2 – Materials and Methods 
 
 
2.1 Animals  
 
Wild type (WT) C57BL/6 (B6) and CD45.1+ B6 mice were purchased from The Jackson 
Laboratory. All mice used in this study were housed under pathogen-free conditions in the 
University of Pennsylvania Animal Care Facilities. All animal protocols used were pre-approved 
by the Institutional Animal Care and Use Committee of the University of Pennsylvania. 
 
2.2 Generation and genotyping of Tnfaip8-/- mice 
 
The B6 ES cell line with a disrupted Tipe gene (NM_134131) was obtained from the Texas A&M 
Institute for Genomic Medicine (College Station, Texas). The gene-trapping vector that disrupts 
Tipe gene was inserted into the only intron of the gene (Figure 2A). The ES cells were injected 
into mouse blastocysts to generate chimeras. Six chimeras, one female and five males, were 
produced. The germline transmission was obtained from one of the male chimeras. A common 
WT primer 1 (5’-GTTTCATATCCATCTCTTATA-3’) was paired with (i) a reverse primer 3(5’-
CCAATAAACCCTCTTGCAGTTGC-3’) against the sequence on gene trap vector to produce a 
178 bp PCR fragment from Tipe-deficient allele, and (ii) WT reverse primer 2 (5’-
TGGCGTGACTTGAGTGCTTC-3’) to generate a 334 bp PCR fragment from the wild type allele. 
Heterozygous mice for the disrupted Tipe locus were bred to produce homozygous Tipe-/- 
animals. Once identified, they were further tested by PCR to ensure that that did not express 
TIPE mRNA using primers 4 (5’-ACCTGGCCGTTCAGGCACAA-3’) and primer 5 (5’-
TCACCCTGTACAGCTCATCT-3’) (Figure 2B). 
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Figure 2. Generation of Tnfaip8-knockout mice by gene targeting 
(A) The wild-type Tipe (Tnfaip8) gene locus and the knockout allele. LTR: viral long terminal 
repeat; SA: splice acceptor; Neo: Neomycin-resistant gene; pA: poly adenylation sequence. 
Arrows indicate the locations of PCR primers. (B) Genomic DNA was extracted from mice tails. 
PCR was performed using primers shown in Panel A (primers 1, 2, and 3). WT band: 334 bp; 
Tipe knock out band: 178 bp. (C) Total RNA was isolated from the indicated organs of WT and 
Tipe-/- mice; RT-PCR was performed using the Tipe primers shown in Panel A (primers 4 and 5).  
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2.3 Phenotyping of Tnfaip8-/- mice  
 
Six-to-eight-week age-matched WT and knockout mice were sacrificed and their immune organs 
were collected and weighted. Single cell suspensions were prepared from them. Total cell 
numbers from each organ were determined using the COULTER Counter (Beckman). Flow 
cytometry was performed after staining cells with anti-mouse CD4, CD8, B220, Gr-1, CD11B, 
CD11C, NK1.1, CD25, CD44, Foxp3, CD62L and CD69. All the antibodies used were purchased 
from BD Bioscience. 
 
2.4 Bone marrow chimeras 
 
Bone marrow cells were flushed from the femurs and tibias of donor mice. The red blood cells 
were lysed with ACK solution (8.29 g NH4Cl, 1 g KHCO3, and 37.2 mg Na2EDTA in 1L of water). 
Cells were washed twice and re-suspended in cold PBS. Recipient mice were sub-lethally 
irradiated with 500 rads twice separated by 4 hours. The irradiated mice received a total of 
10x106 donor bone marrow cells by tail vein injection one or two hours after irradiation. Mice were 
used seven to eight weeks later for experiments.  
 
2.5 RT-PCR 
 
Total RNA was isolated from brain, spinal cord, lung, liver, heart, spleen, intestine, and 
mesenteric lymph nodes of wild type and Tnfaip8-/- mice with Trizon reagent (Sigma) according to 
the manufacturer’s instruction. The isolated RNA was further purified with RNeasy Mini kits 
(Qiagen) according to the manufacturer’s instruction. 250ng of RNA samples were reversely 
transcribed with oligo(dT) and SuperScript II transcriptase (Invitrogen). The generated cDNA was 
 13 
diluted with sterile Milli-Q water (1:4). Real-time quantitative PCR analysis was performed using 
specific Quantitect Primers for mouse GAPDH, TNFAIP8, TIPE1, TIPE2, TIPE3, IL-6, IL-1β, IL-
17, and CXCL2 (Qiagen) in an Applied Biosystems 7500 system using Power SYBR Green PCR 
Master Mix (Applied Biosystems). Relative levels of gene expression were determined with 
GAPDH as the control.  
 
2.6 Cell lines and plasmids  
 
The HEK293T, NIH 3T3, and Hepa1-6 cells were cultured in D10 (DMEM with 1% penstrep, 1% 
L-glutamine, and 10% FCS or 10% CS for 3T3 cells). Full-length TNFAIP8 cDNA was generated 
by PCR and cloned in frame with an N-terminal Flag into vector pRK5. Human wild-type RAC1, 
RAC1 T17N, RAC1 Q61L cDNAs were obtained from Addgene and subcloned into pRK5 with 
Myc or HA tag at the N terminus. Truncated forms of Rac1 lacking the N-terminal amino acids 1–
47 and C-terminal amino acids 162–192 or 189–192 were generated by PCR and cloned in-frame 
with an N-terminal HA tag into vector pRK5. cDNAs encoding TNFAIP8, wild-type RAC1, RAC1 
T17N and RAC1 Q61L were subcloned into the pEGFP-N3 plasmid. 
 
2.7 Plasmid DNA transfection and viral infection 
 
293T cells were transfected with plasmid DNA using Fugene 6 (Promega) reagent according to 
the manufacturer’s instructions. For virus production, pLKO.1 (with puromycin resistance) with 
shRNA-Tnfaip8 (purchased from Open Biosystems) or shScr (a non-specific scramble shRNA 
purchased from Addgene) fragments and packaging constructs were co-transfected into 293T 
cells. After 24 and 48 hrs, virus-containing medium was filtered and used to infect Hepa1-6 and 
3T3 cell lines in the presence of 6.5 mg/ml of polybrene (Millipore). Infected cells were selected 
using puromycin (Sigma) to establish shRNA-Scr, shRNA-Tnfaip8-1 (SH1), and shRNA-Tnfaip8-2 
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(SH2) cell lines. Viral vectors were produced from the pLKO.1 plasmid containing SH1 
(AAAGGGATTGTACAAGGCAGC), SH2 (TTGAACTGATTGTTCCTGTGG), or shRNA-scr 
(CGAGGGCGACTTAACCTTAGG). 
 
2.8 Microbial strains and infection  
 
Wild-type L. monocytogenes (10403s) were provided by H. Shen and Y. Paterson (University of 
Pennsylvania). L. monocytogenes and Staphylococcus aureus (ATCC 29213) were grown at 37 
°C in brain-heart-infusion medium (Becton Dickinson), and Columbia medium with 2% NaCl, 
respectively. For all assays, mid-log-phase bacteria were used. Bacterial in vitro infection was 
assayed in 6-well plates. A total of 7.5 × 105 Hepa1-6 cells were seeded in each well, followed by 
culturing overnight in DMEM with 10% FBS. Cells were the serum starved for 18-24 hours. Cells 
were infected with L. monocytogenes at multiplicity of infection (MOI) of 50 in antibiotic-free 
media. Sixty minutes after the inoculation, cells were washed three times with PBS, and fresh 
medium containing gentamycin (150 μg/mL) was added. At 1.5 hours after infection, cells were 
lysed with 0.1% Triton in PBS and serial dilutions of the homogenate were plated on brain-heart 
infusion agar plates (BHI) (Becton Dickinson). The colonies were counted 24 hours later. For in 
vivo bacterial infection, L. monocytogenes was grown in brain-heart-infusion medium until the 
absorbance at 600 nm reached 0.1 of optical density. S. aureus was grown in Columbia media 
with 2% NaCl. Six- to 7-wk old WT and TNFAIP8 KO mice were infected intravenously with 2 × 
105 L. monocytogenes in 200 μL PBS or 2 × 107 S. aureus in 200 μL saline. For measurement of 
the bacterial burden in liver and spleen, mice were sacrificed 72 h after inoculation, organs were 
homogenized in 0.1%Triton in PBS, and serial dilutions of the homogenate were plated on BHI 
agar plates. The colonies were counted 24 h later. Serum alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) levels were determined using the Infinity ALT or AST liquid 
stable reagent (Thermo). 
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2.9 DSS-induced colitis  
 
Experimental colitis was induced with 3% or 4% (w/v) DSS (MW 36-40kDa; MP Biologicals) 
dissolved in sterile, distilled water ad libitum for 5 days followed by normal drinking water until the 
end of experiment. For survival studies, eight-to-ten weeks old mice were treated with 4% DSS 
for five days and replaced with normal drinking water until day 14. For histology, gene expression 
and cytokine production studies, mice were treated with 3% DSS for 5 days followed by regular 
drinking water for two days and euthanized at different time points after the DSS treatment.  
 
2.10 Determination of clinical scores 
 
Body weight, stool consistency, and rectal bleeding were monitored daily 11. In brief, stool scores 
were determined as follows: 0, well-formed pellets; 1, soft and semiformed but didn’t adhere to 
the anus; 2, semiformed but adhere to the anus; 3, liquid stool. Bleeding scores were determined 
as follows: 0, no blood; 1, blood traces in rectum; 2, visible blood in whole rectum; 3, gross rectal 
bleeding. Weight loss scores were monitored as follows: 0, no body weight change; 1, body 
weight loss within 5%; 2, body weight loss within 10%; 3, weight loss within 20%; 4. Body weight 
loss exceeds 20%.  DAI (disease activity index) was the total sum of these 3 scores. 
 
2.11 Histopathology and immunohistochemistry  
 
The entire colon was excised to measure the length. The distal colons were washed, fixed in 10% 
buffered formalin and embedded in paraffin. Tissue sections were stained with hematoxylin & 
eosin (H&E). For Ki-67 and active caspase 3 staining, mice were treated with DSS and colon 
were collected, processed, and stained with Ki-67 and active caspase 3 antibody.  
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2.12 Isolation of colon epithelial cells  
 
Colonic epithelial cells were isolated as described16. In brief, colons were dissected, washed with 
cold PBS, and cut into small pieces. Colon segments were incubated in PBS supplemented with 
1mM EDTA and 1mM DTT for 30min at 37oC with gentle shaking. Cells in supernatants were 
filtered through a 70 μm cell strainer and washed twice. Enrichment for colonic epithelial cells 
was confirmed by staining cells for the epithelial cell-specific marker EpCam (eBioscience). 70-
80% of isolated cells stained positive for EpCam. If needed, the isolated colonic epithelial cells 
were cultured in epithelial cell culture medium (ECM) containing equal volumes of phenol-red-free 
DMEM and Ham’s F-12 medium (Biowhittaker) with the following additives: 5 μg of insulin 
(Sigma)/ml, 5x108 M dexamethasone (Sigma), 60 nM selenium (Sigma), 5x108 M triiodothyrenine 
(Sigma), 5 μg of transferrin (Sigma)/ml, 10 ng of Eidermal growth factor (Sigma)/ml, 20 mM 
HEPES, 2 mM glutamine, 10% Penicillin/streptomycin, and 2% FBS.  
 
2.13 Colon leukocytes isolation  
 
Colon leukocytes were isolated using a modified version of a previously described protocol17. 
Briefly, colon was washed 3 times and incubated in PBS with 5% FBS, 2mM EDTA, 1mM DTT for 
15 min at 37oC with shaking (250 RPM). This was repeated 3 times to remove epithelial cells. 
The colon samples without epithelial cells were digested in PBS with 5% FBS, 0.5 mg/ml 
collagenase (Sigma), 0.02 mg/ml Dnase (Roche), and 0.1 mg/ml Dispase (Invitrogen), for 20 
minutes at 37℃ with gentle shaking for another 45 min with shaking at 37oC.  The mixture then 
was filtered through 70 μm cell strainer. The flow through contains colon leukocytes.  
 
2.14 Blood cell counts 
 
 17 
Before euthanizing the mice, blood was collected, and whole blood cell counts were determined 
using Drew Hemavet 950FS (Drew Scientific, Oxford, U.K.). 
 
2.15 Bacterial culture  
 
Colon samples were collected and processed as described above, and then homogenized in 
CelLyticTM M buffer (Sigma) and serially diluted. Different dilutions of the tissue homogenates 
were plated in triplicates on blood agar (BD Bioscience) and BHI agar. The bacterial colonies 
formed were counted after incubating at 37oC for 24 hrs.  
 
2.16 Macrophage and neutrophil preparations  
 
To generate bone marrow-derived macrophages (BMDMs), bone marrow cells were flushed from 
the femurs and tibias of donor mice. The red blood cells were lysed with ACK solution (8.29g 
NH4Cl, 1g KHCO3, 37.2mg Na2EDTA in 1L of water). Cells were washed twice in ice-cold 
1xDPBS and cultured for 7 days in 30% L-929 cell culture supernatant and 70% DMEM 
containing 10% (vol/vol) heat-inactivated FBS, 2 mM L-glutamine, and 100 units/mL 
penicillin/streptomycin (D10). Cells were washed twice with cold DPBS and collected with 5 mM 
EDTA in DPBS. After centrifugation, they were resuspended in D10 and rested for 24 h before 
experimentation. BMDMs were >95% CD11b+ and F4/80+ as determined by flow cytometry. 
Morphologically mature neutrophils were purified from murine bone marrow by Percoll gradient 
centrifugation. Briefly, bone marrow cells were harvested from mice using neutrophil isolation 
buffer (1× HBSS without Ca2+ and Mg2+ containing 0.25% BSA). After RBC lysis, cells were 
layered on a 62% Percoll gradient. Following centrifugation at 1,200 × g for 30 min at room 
temperature, pelleted cells were removed and washed once with isolation buffer before being 
used in the experiment. Neutrophil viability was >95% according to results from trypan blue 
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staining. Purity was typically 75–85% as assessed by flow cytometry based on forward and side 
scatter and Gr1 staining.  
 
2.17 Phagocytosis assay.  
 
To prepare apoptotic cells for phagocytosis assay, thymocytes were harvested from 3- to 4-wk-
old C57BL/6 mice, loaded with 10 uM carboxyfluorescein succinimidyl ester (CFSE) (Molecular 
Probes) for 10 minutes at 37°C and washed 2X in PBS. Apoptosis was induced by incubation at 
37°C in 5% CO2 for 5 h in the presence of 5 μM dexamethasone (Sigma-Aldrich). After 
dexamethasone treatment, cells were washed three times with PBS and resuspended in DMEM 
with 2% FBS. This treatment routinely yielded over 70% apoptotic thymocytes as measured by 
annexin V staining. Phagocytosis assay was performed in a 12-well nontissue culture-treated 
plate (BD Falcon). A total of 1 × 106 BMDMs were seeded in each well, followed by culturing 
overnight in DMEM with 2% FBS. CFSE+ apoptotic thymocytes were then added at a ratio of 5:1, 
and centrifugation was performed at 500 × g for 2 min to synchronize binding and internalization. 
After 30 min of incubation at 37 °C, plates were rapidly washed two times with ice-cold PBS, and 
cells collected with 5 mM EDTA-PBS. Cells were then fixed with 2% paraformalhyde in PBS, 
stained with APC-conjugated anti-F4/80, and analyzed by flow cytometry. Gates were set for 
macrophages in FSC/SSC dot blots. Experiments using fluorescent latex beads (2 μm; Sigma-
Aldrich) were performed in a similar fashion. For bacterial phagocytosis assay, L. monocytogenes 
were washed twice with sterile PBS and incubated (at 1 × 109/mL bacteria) in 2 μM CFSE for 20–
30 min under constant shaking at 37 °C. CFSE-labeled bacteria were washed three times with 
PBS before being used. Live bacteria were fed to BMDMs at a ratio of 10:1 in DMEM with 10% 
serum. 
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2.18 Chemotaxis assay 
 
Primary neutrophils were loaded with 5 μM Calcein AM in PBS supplemented with 2% FBS for 30 
minutes at 37°C. After 3 washes with PBS, neutrophils were resuspended to with 2 × 106 cells 
per ml of PBS. ChemoTX plates (Neuro Probe) were loaded with 50 μl of cell over each 5.7mm 
diameter chamber with 5 μm pores. The lower chambers were loaded with 30 μl of PBS 
containing the specified concentration of IL-8. The Neutrophils were incubated for one hour, and 
then the top chambers were washed off and the plates were read in a fluorescent plate reader. 
Chemotactic index was calculated as the number of neutrophils in the lower chambers of 
chemokine containing wells over the wells with no chemokines. 
 
2.19 ELISA  
 
The colon homogenates and serum were collected and stored at -80oC. Sera were collected from 
WT and TNFAIP8 KO mice 72 hours after L. monocytogenes infection and kept at −80°C. 
Antibodies used in ELISA were purchased from BD Pharmingen and eBioscience, including 
purified and biotinylated rat anti-mouse IL-6, IL-17A, IL-1β, and TNFα. Quantitative ELISA was 
performed using paired mAbs specific for corresponding cytokines according to the 
manufacturer’s recommendations. 
 
2.20 Cell death and proliferation  
 
Colon samples were processed and epithelial cells were obtained from control and colitis WT and 
Tipe-/- mice. The isolated epithelial cells were collected and cell death was determined by 7AAD 
and Annexin V staining. Alternatively, Tipe knockdown 3T3 cells were treated with 3% DSS for 16 
hrs and the cells were harvested for 7AAD and Annexin V staining. The in situ colonocyte 
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proliferation was assessed by Ki67 staining and cell death was determined by active caspase 3 
staining after the colon tissues were collected from DSS-treated mice and fixed in 10% buffered 
formalin and embedded in paraffin. 
 
 
2.21 TNFα stimulation 
 
Hepa1-6 cell lines were serum starved for 16 hours in DMEM containing 2mM L-glutamine, and 
100 units/mL penicillin/streptomycin. Cells were treated with 10 ng/ml of TNFα for 0, 1, 5, 15, 30, 
60 minutes for protein lysates, or with 5 ng/ml TNFα plus 20 ng/ml cyclohexamide (CHX) for 7 or 
16 hours. Death was measured by flow cytometry using Annexin V PE and 7-AAD (BD 
Pharmingen) staining. For measuring death following RAC1 mutant transfections, EGFP positive 
cells were gated on for comparison. To inhibit RAC1, cells were incubated with inhibitor 
Z62954982 (Millipore) at 100µM for 30 min prior to experimental treatment. 
 
2.22 Western blot 
 
For Western blot analysis, cells were lysed for 20 min at 4°C in 1% Triton X-100 lysis buffer 
containing protease and phosphatase inhibitors. Cell debris was removed by centrifugation at 
14,000 × g for 20 min at 4°C. For subcellular fractionation, membrane and cytoplasmic proteins 
were separated using Qproteome Cell Compartment Kit (QIAGEN) according to the 
manufacturer’s instructions. The protein concentration of the lysates was determined by Bradford 
assay. Equal amounts of total protein were resolved by SDS-PAGE, transferred to membranes, 
immunoblotted with specific primary and secondary antibodies, and the signals were detected by 
chemiluminescence (Pierce). Primary antibodies against p-AKT(S473), AKT, Myc, as well as anti-
Myc conjugated to HRP, were purchased from Cell Signaling Technology and used according to 
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the manufacturer’s instructions. Anti-TNFAIP8 (1:500) was purchased from ProteinTech Group 
and Anti-RAC1 (1:500) was purchased from Millipore. Anti-Flag (1:2000), anti-Flag-M2-HRP, anti-
β-actin (1:3000) and anti-GAPDH antibody (1:3000) were purchased from Sigma. HRP-
conjugated secondary anti-mouse and anti-rabbit IgG (1:1500) were purchased from GE 
Healthcare. The densitometric quantification of Western blot signals was performed using ImageJ 
software. Paired t-test was used to evaluate the statistical significance of the results.  
 
2.23 Immunoprecipitation 
 
Immunoprecipitation was performed using Dynabeads protein G (Invitrogen). In brief, 1.5 mg 
protein-G Dynabeads was coated with 5 μg specific antibodies or Ig control for 1 h at room 
temperature with rotation. After removing unbound antibody, the bead–antibody complex was 
incubated with 500 μL cell lysate for 4 h at 4 °C with rotation. The captured Dynabead-Ab-Ag 
complex was washed four times with PBS and boiled in 2× Laemmli buffer. The eluted proteins 
were fractionated by SDS-PAGE and detected by Western blot. 
 
2.24 Loading of RAC1 with GDP and GTP 
 
The 293T cells were transiently transfected with Myc-tagged RAC1 and Flag-tagged TNFAIP8 for 
18 h. Cells were lysed in cell lysis buffer (50 mM Tris, pH 7.5, 10 mM EDTA, 0.2 M NaCl, 0.5% 
Nonidet P-40, and 1× protease inhibitors mixture) (Roche). A total of 1 mM GDPβS or 0.2 mM 
GTPγS (Enzo Life Sciences) was loaded to transfected cell extracts. After 20 min incubation at 30 
°C, samples were placed on ice immediately and MgCl2 was added to a final concentration of 10 
mM to stop nucleotide exchange. 
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2.25 PAK Pull-Down Assay  
 
Hepa1-6 cells were serum starved for 16 hours, and then treated with 10 ng/ml TNFα for 5 
minutes. The cells were washed in PBS and lysed in PBD lysis buffer (50mMTris, pH 7.5, 10 mM 
MgCl2, 0.2 M NaCl, 2% Nonidet P-40, and 1× protease inhibitors mixture) (Roche). The lysate 
was incubated with 20 μg of p21-activated kinase (PAK)-GST protein beads (Cytoskeleton) for 30 
min at 4 °C. After washing, protein on beads and in total cell lysates was subjected to Western 
blot to determine the level of active Rac.  
 
2.26 Statistical analysis 
 
Quantitative data are presented as means±SEM of two or three experiments. Survival curves 
were plotted via the Kaplan-Meier method and compared by the log-rank test. Two-tailed Student 
t test was used for all other results and p<0.05 was considered statistically significant. All 
statistical analysis was performed using Graphpad Prism Software.  
 
 
 23 
Chapter 3 – Listeriosis 
3.1 Introduction 
 
TNFα-induced protein 8 (TNFΑIP8 or TIPE), also known as SCC-S2, OXI-α, GG2-1, 
NDED, and MDC-3.13, is the first described member of the TNFΑIP8 family. It is an NF-κB 
inducible protein upregulated in metastatic head and neck squamous cell carcinoma cell lines, 
and to protect cancer cells from TNFα-induced apoptosis (Patel et al. 1997; Kumar et al. 2000). 
Overexpression in tumor cell lines also enhanced proliferation and migration (Kumar et al. 2004). 
TNFΑIP8 polymorphisms have been found to be a risk factor for non-Hodgkin’s lymphoma in 
humans and Staphylococcus aureus infection in mice (Ahn et al. 2010; Zhang, Wang, et al. 
2012). A few TNFAIP8 interacting partners have been identified, including activated Gαi3 and 
Karyopherin α2 (Laliberté et al. 2010). TIPE2, a closely related TNFAIP8 family protein, has been 
reported to interact with RAC1 and to protect against Listeria monocytogenes infection (Wang et 
al. 2012). 
Listeria monocytogenes is a predominantly food-borne pathogen with ~10 cases per 
million inhabitants in most industrialized countries.  Despite having a lower incidence of infection 
than most other food-borne pathogens, listeriosis carries a high risk of mortality ranging between 
20-30%, and accounts for 19% of food-borne disease-related deaths in the USA (Mateus et al. 
2013; Hernandez-Milian & Payeras-Cifre 2014). L. monocytogenes is an intracellular gram-
positive bacterium that infects a number of cell types including hepatocytes, neurons, and 
immune cells. Immune cell-mediated apoptosis of L. monocytogenes-infected cells such as 
hepatocytes is important for resolving infection (Vázquez-Boland et al. 2001). The innate immune 
system is vital for controlling the infection until the adaptive immune system generates enough 
cytotoxic T lymphocytes (CTLs) to finally clear the pathogen. Key immune cells are macrophages 
and neutrophils that release inflammatory molecules and phagocytose extracellular bacteria 
(Shaughnessy & Swanson 2007; Wing & Gregory 2002; Cousens & Wing 2000). TNFα and IL6 
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are key inflammatory cytokines that are important in controlling the infection, and the loss of 
either results in susceptibility to infection (Hoge et al. 2013; Abreu et al. 2013). In this chapter, we 
sought to characterize L. monocytogenes infection in TNFAIP8 knockout mice and we show that 
TNFAIP8 sensitizes mice to lethal L. monocytogenes infection through a mechanism involving the 
non-immune system. These results may provide new insights into TNFAIP8’s regulation of 
listeriosis and carcinogenesis. 
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3.2 Results 
 
3.2.1 TNFAIP8 knockout mice are resistant to lethal Listeria monocytogenes infection  
It has been previously reported that TIPE2-deficient mice are resistant to L. 
monocytogenes infection (Wang et al. 2012).  We hypothesized that TNFAIP8-knockout mice 
might have a similar phenotype. To test this, TNFAIP8 knockout (KO) and wild type C57BL/6 
mice were intravenously injected with a lethal dose of L. monocytogenes. As expected, TNFAIP8 
knockout mice were found to be resistant to death (Figure 3A), and experienced reduced weight-
loss during infection (Figure 3B). Next we examined the bacterial load in the liver and spleen 3 
days post infection, and found reduced bacterial load in the knockout mice (Figure 4A). We 
assessed liver damage by measuring serum levels of ALT and AST, but we found no significant 
differences between wild type and knockout mice (Figure 4B). Serum TNFα and IL-6 levels were 
also assayed. TNFα and IL-6 are important for controlling L. monocytogenes, and mice deficient 
in either of them have increased bacterial burden (Miura et al. 2000). Although the knockout mice 
had less TNFα and more IL-6, the differences were not statistically significant (Figure 5).  
Therefore TNFAIP8 KO mice are resistant to lethal L. monocytogenes infection, independent of 
serum cytokines and hepatocellular toxicity. 
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Figure 3. L Monocytogenes infection in Tnfaip8-/- mice 
Wild type (n=5) and TNFAIP8 knockout mice (n=7) were infected with 2x105 CFUs of L. 
monocytogenes through the tail vein. (A) Mouse Kaplan-Meier survival curve after L. 
monocytogenes injection (P = 0.01). (B) Changes in body weight following infection (P = 0.04).  
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Figure 4. Liver and spleen bacterial load and damage 
Wild type (n=5) and TNFAIP8 knockout (n=5) mice were sacrificed at day 3 post infection and 
their livers, spleens, and sera collected. (A) Spleen and liver bacterial load was measured by a 
colony-forming assay. (B) Serum levels of aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT). The results are representative of at least two independent experiments. 
N.S., not significant; * P < 0.05.
A 
B 
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Figure 5. No statistical difference in TNFα and IL-6 in infected mice 
Serum TNFα and IL-6 levels were measured in wild type (n=5) and TNFAIP8 knockout (n=5) 
mice by ELISA 3 days following L. monocytogenes infection. The results are representative of at 
least two independent experiments.  
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3.2.2 TNFAIP8 deficiency does not protect mice from Staphylococcus aureus infection 
 Next we tested whether there was a difference in mouse survival with another gram-
positive pathogen. We chose Staphylococcus aureus because susceptibility is associated with 
the Tnfaip8 locus in mice (Ahn et al. 2010). TNFAIP8 knockout (KO) and wild type (WT) mice 
were infected intravenously with a lethal dose of S. aureus, but there was no difference in mouse 
survival (Figure 6). We also tested susceptibility to the gram-negative pathogen Escherichia coli 
and again we found no difference (data not shown). These results suggested that bacterial 
resistance in TNFAIP8 knockout mice was dependent on the nature of the pathogen, since L. 
monocytogenes is an intracellular parasite while S. aureus and E. coli are both extracellular. 
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Figure 6. No difference in S. aureus infection 
Wild type (N=5) and TNFAIP8 knockout mice (N=7) were challenged with 2x107 CFUs of 
Staphylococcus aureus. The difference in survival between the two groups is not statistically 
significant.  
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3.2.3 No difference in immune cell function in Tnfaip8-/- mice 
To investigate if there were differences in innate immune cell function, we isolated 
neutrophils from bone marrow and checked if there was a difference in neutrophil chemotaxis. 
We found no significant difference between WT and KO cells in chemotaxis towards IL-8 in a 
Boyden chamber assay (Figure 7A). We next studied the phagocytic capacity of bone marrow-
derived macrophages and found that there were no differences between WT and KO cells in the 
phagocytosis of killed CFSE-labeled thymocytes, fluorescently labeled beads, or L. 
monocytogenes (Figure 7B). To determine whether TNFAIP8 deficiency affects the production of 
TNFα and IL-6 in response to peptidoglycan (PGN), a major component of Gram-positive 
bacteria, we treated bone marrow-derived macrophages with PGN in vitro and assayed the 
supernatant. No difference was detected in the production of TNFα and IL-6 upon stimulation with 
PGN (Figure 8A). Similarly, we injected PGN into WT and TNFAIP8 KO mice, and checked the 
serum levels of the cytokines. Again, we did not find any significant differences between the two 
groups (Figure 8B). Taken together, these results suggest that the innate immune system does 
not play a primary role in the resistance to lethal L. monocytogenes infection in TNFAIP8 
knockout mice.  
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Figure 7. No difference chemotaxis or phagocytosis 
(A) Calcein AM-labeled primary neutrophils were incubated for 1 hour in a Boyden chamber filled 
with or without 50 ng/ml or 500 ng/ml of IL-8.  The rate of chemotaxis was determined using a 
fluorescent plate reader. (B) Bone marrow-derived macrophages (BMDMs) were incubated with 
2-μm fluorescent beads at a ratio of 1:20, apoptotic CFSE-labeled thymocytes at a ratio of 1:5, or 
CFSE-labeled L. monocytogenes at a ratio of 1:10 for 30 minutes. The rate of phagocytosis was 
measured by flow cytometry. The results are representative of at least two independent 
experiments. N.S., not significant. 
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Figure 8. No difference in TNFα and IL-6 production 
(A) BMDMs were treated with PGN (10 μg/ml) for 8 hours and TNFα and IL-6 levels were 
assayed in the supernatant. (B) Wild type and TNFAIP8 knockout mice were intravenously 
injected with PGN (10 mg/kg) and serum was collected after 8 hours to assay TNFα and IL-6 
levels by ELISA. The results are representative of at least two independent experiments. N.S., 
not significant. 
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3.2.4 Non-hematopoietic cells may be responsible for resistance to lethal infection  
We observed little difference in innate immune cell function between wild type and 
knockout mice, suggesting that other tissues may be responsible the resistance observed in 
knockout mice. To test whether TNFAIP8 knockout immune cells are important for the resistance 
to L. monocytogenes infection, we produced bone marrow chimeric mice using both wild type and 
knockout irradiated mice as recipients of wild type bone marrow (Figure 9). The chimeric mice 
had their hematopoietic compartment replaced with donor cells, allowing us to test whether the 
immune cells (derived from the bone marrow) or non-immune cells are responsible for resistance 
to lethal infection. After the immune cells were replenished, the recipient mice were challenged 
with a lethal dose of L. monocytogenes. TNFAIP8 knockout mice still exhibited significant 
resistance to lethal infection despite reconstitution with WT bone marrow (Figure 10). This result 
suggests that the differences in bone marrow-derived immune cells between wild type and 
knockout mice are not responsible for resistance to lethal L. monocytogenes infection in Tnfaip8-/- 
mice. 
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Figure 9. Generation of bone marrow chimeric mice 
Bone marrow cells were flushed from the femurs and tibias of donor wild type mice and 
resuspended in PBS. Recipient wild type and Tnfaip8-/- mice were sub-lethally irradiated with 500 
rads twice separated by 4 hours. The irradiated mice received a total of 10x106 donor bone 
marrow cells by tail vein injection one hour after irradiation. Mice were given 8 weeks to 
reconstitute their immune systems before being challenged with L. monocytogenes.  
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Figure 10. Replacing Tnfaip8-/- bone marrow with wild type does not ablate resistance to 
lethal L. monocytogenes infection 
Bone marrow chimeras were produced by irradiating wild type (N=6) and TNFAIP8 (N=6) 
knockout mice and transferring wild type bone morrow into them. Mice were given 8 weeks to 
reconstitute their immune system before being infected with 2x105 CFUs of L. monocytogenes. 
The difference in survival between the two groups is statistically significant (P = 0.02). 
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3.3 Discussion 
 
Listeria monocytogenes pathogenesis is dependent on a number of factors related to 
both immune and non-immune systems. Hepatocytes are quickly invaded by L. monocytogenes 
upon infection, and apoptotic cell death is important in releasing TNFα and other cytokines to 
trigger an immune response in the infected liver (Pamer 2004; Vázquez-Boland et al. 2001; 
Rogers et al. 1996; Santos et al. 2005). Neutrophils are attracted to the infected organs to 
phagocytose and kill bacteria. If the pathogen is not controlled, L. monocytogenes will escape to 
other organs and the organism can die of sepsis. Protecting immune cells from death has been 
found to be an important aspect in preventing lethal L. monocytogenes infection (Zheng et al. 
2004; Gurung et al. 2011). But promoting cell death in hepatocytes or blocking cellular invasion 
might be equally important for the survival of the organism (dos Santos et al. 2011; Santos et al. 
2005; Schmeck et al. 2006).  
Our results show that TNFAIP8 knockout animals are resistant to lethal L. 
monocytogenes infection with decreased bacterial load in the liver and spleen (Figures 3-4), 
similar to what has been previously observed with TIPE2 (Wang et al. 2012). However, unlike 
TIPE2 knockout mice that show heightened immunity to L. monocytogenes, there was little 
difference in phagocytosis, chemotaxis, or cytokine production between WT and TNFAIP8 KO 
innate immune cells (Figures 5-8).  Despite reports suggesting a role for TNFAIP8 in 
Staphylococcus aureus infection, we found no difference in survival between WT and TNFAIP8 
KO mice (Figure 6) (Ahn et al. 2010). This suggests that TNFAIP8 knockout mice are not 
resistant to extracellular pathogens, and that the immune system is no more capable of handling 
pathogens than that of WT mice. The association of the Tnfaip8 locus with S. aureus resistance 
may have been a statistical anomaly and an alternative locus or a nearby gene may have been 
more important to S. aureus susceptibility. Rather, the non-immune cells of the TNFAIP8 
knockout mice, such as hepatocytes, may be more important in protecting the host against 
pathogens as has been suggested by the chimeric experiment (Figure 10). 
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The resistance of TNFAIP8 knockout mice to lethal infection suggests that TNFAIP8 
plays an important role during the course of the disease. TNFAIP8 mRNA is found in immune 
cells of normal mice but the lack of a phenotype in knockout immune macrophages and 
neutrophils may be due to compensation by TIPE2. TIPE2 is strongly expressed in the immune 
system and it is a regulator of phagocytosis, cell migration and cytokine production, and any 
effect from TNFAIP8 deficiency might have been too weak to detect (Sun et al. 2008; Wang et al. 
2012). With a phenotype too weak to detect and the fact that the chimeric mice retained 
resistance to lethal infection despite having a portion of their immune system replaced with wild-
type cells, differences in the immune system might not have been important enough to confer 
resistance to lethal infection in TNFAIP8 knockout mice. The chimeric experiment does not, 
however, definitively prove that the immune system is not important. A Technical issue with the 
procedure is that it will not completely ablate the original immune system. Tissue resident 
macrophages and other non-dividing long lived immune cells will not be completely killed by the 
irradiation and those cells may be significantly different in knockout mice. As they are not easily 
replaced during the formation of bone marrow chimeras, there may have been enough TNFAIP8 
knockout resident macrophages left in knockout chimeric animals to protect them from L. 
monocytogenes. In addition, due to limitations in the number of mice available for the 
experiments, chimeric mice reconstituted with knockout bone marrows were not created, so it is 
not possible to completely rule out a protective effect of the knockout immune system. Another 
issue is that the chimeric animals had overall increased susceptibility to death by L. 
monocytogenes infection compared to the mice in figure 3. Possible explanations include the 
difference in the ages of the mice, the collateral damage of the irradiation on the murine tissues 
increasing susceptibility to infection, incomplete immune reconstitution resulting in a weaker 
immune response, and standard error in the experimental results. Despite these limitations, the 
results support the hypothesis that non-immune cells play an important role in infection. The lack 
of resistance to extracellular pathogens and the lack of a clear phenotype in immune cells 
suggest that the resistance to lethal L. monocytogenes infection is due to the nature of the 
 39 
intracellular pathogen and its ability to infect and survive in host cells, and so the attention must 
turn to alternative explanations involving non-immune cells. 
TNFα is critical for protecting mice against lethal L. monocytogenes infection, which can 
block certain aspects of TNFα signaling to protect itself (Miura et al. 2000; Gouin et al. 2010). 
Both IL-6 and TNFα levels varied greatly depending on the significance of infection within each 
experimental set, but no statistical difference was observed. A difference may be present and 
relevant to the resistance found in knockout animals, but a greater sample of animals and more 
stringent conditions may be necessary to detect it. Despite there being no statistical difference in 
serum levels of TNFα in infected mice, TNFAIP8 being an inducible gene of TNFα may explain 
why knockout mice were resistant. TNFAIP8 is protective against TNFα induced death, and 
differences in apoptosis of bacteria infected cells may explain the differences in survival of the 
knockout mice. Another potential explanation may be that TNFAIP8 knockout cells are resistant 
to infection by the bacteria. L monocytogenes depends on its ability to invade hepatocytes to 
evade the immune system. Inflammation is harmful to bacteria, and neutrophils and macrophages 
are constantly on the lookout for extracellular pathogens but are helpless against invaders hidden 
within other cells (Vázquez-Boland et al. 2001). By invading a cell and preventing its death, the 
bacteria can safely proliferate until it is ready to spread to surrounding cells. Therefore, it is logical 
to form the hypothesis that TNFAIP8-knockout mice are protected against lethal L. 
monocytogenes infection by first reducing hepatocyte invasion and second by increasing 
apoptosis of infected hepatocytes in response to TNFα, thus blocking a productive infection of the 
pathogen.  
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Chapter 4 – Experimental Colitis 
4.1 Introduction 
 
Human inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s 
disease, are a major health problem in the northern hemisphere and industrialized countries 
(Fiocchi 1998). These diseases are characterized by chronic colonic inflammation and are 
mediated by infiltrating inflammatory cells. Ulcerative colitis is characterized by inflammation 
limited to the large intestine, and has an incidence of 9-12 cases per 100,000 persons in the 
United States (Adams & Bornemann 2013). Crohn’s disease is more common with 20.2 cases 
per 100,000 persons in North America, and it is characterized by inflammation that can occur 
anywhere throughout the entire digestive tract (Laass et al. 2014). IBD is known for its high 
morbidity in patients with any combination of the following symptoms: vomiting, weight loss, 
severe abdominal pain, diarrhea, and rectal bleeding. It is also associated with an increased risk 
of osteoporosis and fracture, arthritis, and hypercoagulability (Targownik et al. 2013; Owczarek et 
al. 2014). Severe IBD resulting in hospitalization is linked with an increased risk of colorectal and 
breast cancers in Asians populations (Peng et al. 2014; Tsai et al. 2014). In addition, mortality 
from infection from bacterial pathogens such as Clostridium difficile is increased in IBD patients 
(Kassam et al. 2014). The etiologic factors that trigger these diseases are not well understood, 
but they are believed to include genetics, diet, psychological factors, immunological factors, 
infection, drugs, and sleep problems (Ek et al. 2014; Sobczak et al. 2014). There is no effective 
cure for IBD aside from a colectomy of the entire large intestines in ulcerative colitis but not in 
Crohn’s disease. The goal of treatment is to reduce discomfort, treat complications, and have the 
disease go into remission, and this is achieved with anti-inflammatory drugs, 
immunosuppressants, corticosteroids, and antibiotics. It is therefore important to determine the 
molecular components that regulate these diseases in order to develop more effective treatment 
therapies. 
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 In mice, oral administration of dextran sodium sulfate (DSS) induces a form of colitis that 
shares many pathological and clinical features with human inflammatory bowel diseases; 
therefore DSS-induced colitis is considered to be a valuable experimental model for human IBD 
(Perše & Cerar 2012; Strober et al. 2007; Diaz-Granados et al. 2000). Increased colon epithelial 
cell death and decreased proliferation have been implicated in the development of colitis. TIPE2 
deficiency in the immune system of mice has been found to be protective against the 
experimentally induced colitis (Lou et al. 2014). In addition, the NF-κB activator IKK-β is linked to 
tumorigenesis due to inflammation in the experimental colitis-associated cancer mouse model, 
and it can regulate both incidence of tumorigenesis and size (Greten et al. 2004). Given the 
potential roles of TNFAIP8 in regulating these processes, we set out to test the in vivo effect of 
TNFAIP8 deficiency in the development of DSS-induced colitis using our newly generated 
TNFAIP8 knockout mice. Our data indicates that TNFAIP8 plays a crucial role in maintaining 
colonic homeostasis during colitis.   
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4.2 Results 
 
4.2.1 Tnfaip8-/- mice are hyper-sensitive to DSS-induced colitis 
Tnfaip8-/- mice do not appear to develop more spontaneous diseases than wild type (WT) 
littermates, unlike Tipe2-/- mice.  However, after drinking DSS-containing water, they developed 
more severe colitis than WT mice. Mice began dying after day 6 and all of the Tnfaip8--/- animals 
died by day 10 while 40% of WT animals were still alive (Figure 11A). The Tnfaip8-/- mice suffered 
greater body weight loss (Figure 11B) and increased overall disease manifestations (Figure 11C). 
To further assess the severity of colitis, colon length was also measured. The DSS-fed Tnfaip8-/- 
mice, but not wild type or untreated mice, had significantly shorter and lighter colons signifying 
increased inflammatory damage (Figure 12A, B, and C). Consistent with these findings, a 
histopathological examination of H&E-stained colons of knockout mice revealed more severe 
colitis characterized by crypt loss, loss of structure, and more infiltrating leukocytes than in the 
controls (Figure 12D). 
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Figure 11. Tnfaip8-/- mice are hyper-sensitive to DSS-induced colitis 
(A) Wild type (WT) mice (n=5) and Tnfaip8-/- (Tipe-/-) mice (n=5) were fed with DSS-containing 
water for five days, followed by regular drinking water. Survival was monitored for two weeks after 
the start of DSS treatment. (B-E) WT and Tnfaip8-/- mice were fed with DSS water for five days, 
followed by regular drinking water for two days.  Body weight  (B) and disease score (C) were 
recorded daily. Disease activity index was the total sum of 3 scores measuring stool consistency, 
rectal bleeding, and body weight loss. These experiments were performed in collaboration with 
Honghong Sun and Yunwei Lou. *P<0.05 
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Figure 12. Tnfaip8-/- colons are more inflamed 
On Day seven, mice were euthanized and colons were harvested (A). Colon weight was 
measured after DSS treatment in wild type and knockout mice (B), and colon length was 
compared with or without DSS treatment (C). Histopathological changes (D) in colon tissues were 
examined by microscopy following H&E staining. Data shown is representative of at least three 
experiments performed in collaboration with Honghong Sun and Yunwei Lou. Scale bar in A, 1 
mm and in D, 50 µm. *P<0.05  
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4.2.2 Enhanced inflammatory response in Tnfaip8-/- mice with colitis 
To further define the roles of TNFAIP8 in DSS-induced colitis, we examined the 
hematological and immunological aspects of the disease in age- and sex-matched Tnfaip8-/- mice 
and WT controls. Significantly increased neutrophil counts were detected in Tnfaip8-/- blood 
samples (Figure 13A). At the same time, the spleens of Tnfaip8-/- mice became smaller (Figure 
13B) while more leukocytes were found in the colon of these mice (Figure 13C). After dissecting 
the leukocyte populations in the colon using surface markers, we found that there were increased 
levels of myeloid derived cells such as macrophages, neutrophils and dendritic cells, and 
increased B-cell but not T-cell lymphocytes infiltrated into the colon (Figure 14). In contrast, 
untreated mice had similar spleen weights and cell type composition of the splenocytes (Figure 
15). Despite the published role of TNFAIP8 in dexamethasone-induced death of thymocytes, we 
saw no difference in knockout cells compared to wild type (Figure 16). Enhanced levels of IL-17A 
and IL-6 were also found in the sera of Tnfaip8-/- mice (Figure 17A).  Similarly, enhanced levels of 
IL-6, IL-17A, and IL-1β proteins (Figure 17B) and/or mRNAs (Figure 17C) were detected in the 
knockout colons. Increased CXCL2 mRNA expression was also detected in Tnfaip8-/- colons 
(Figure 17C). These results point to an enhanced inflammatory response in the Tnfaip8-/- colon 
after DSS treatment that might be responsible for the increased severity of the experimental 
colitis. 
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Figure 13. Increased leukocyte mobilization in Tnfaip8-/- mice.  
Mice (n=4) were treated and sacrificed as described in Figure 11. Increased blood neutrophil 
counts (A) and decreased spleen weights (B) were observed in Tnfaip8-/- mice. The colons from 
WT and Tnfaip8-/- mice were harvested and lamina propria immune cells were isolated (C). These 
experiments were performed in collaboration with Honghong Sun and Yunwei Lou.*P<0.05; 
**P<0.01 
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Figure 14. Increased myeloid and B-cell infiltration in Tnfaip8-/- colon  
The colons from WT and Tnfaip8-/- mice were harvested and lamina propria immune cells were 
isolated. After counting in a hemacytometer, the cells were stained with antibodies to T, B, and 
myeloid cell markers, and analyzed by flow cytometry. Increases in CD11b, CD11c, and B220 
cells were observed. Data shown are representatives of at least three experiments. These 
experiments were performed in collaboration with Honghong Sun and Yunwei Lou. *P<0.05; 
**P<0.01; *** P <0.001 
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Figure 15. No difference in leukocyte numbers in untreated mice 
Eight-week-old wild type and Tnfaip8-/- mice (n=4) were sacrificed. (A) Spleens were removed 
and weighed. (B) Splenocytes were then purified and the cells were stained with antibodies to T, 
B, and myeloid cell markers, and analyzed by flow cytometry. These experiments were performed 
in collaboration with Yunwei Lou. 
 49 
 
 
Figure 16. Dexamethasone-induced cell death was not affected in Tnfaip8-/- thymocytes 
Eight-week-old wild type and Tnfaip8-/- mice (n=4) were sacrificed. Percentages of annexin V 
positive thymocytes treated with dexamethasone (Dex) or without (ctr) in culture for four hours. 
Challenged cells were further divided into double positive cells for CD4 and CD8 (DP), CD4 
single positive, or CD8 single positive cells. Data shown is representative of three independent 
experiments. These experiments were performed in collaboration with Honghong Sun. 
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Figure 17. Increased inflammatory cytokines in serum and colon of Tnfaip8-/- mice 
Wild type and Tnfaip8-/- (n=5) mice were treated with DSS water for five days, followed by regular 
drinking water for two days. Mice were sacrificed and their blood was collected retro-orbitally. 
Colons were harvested and ½ of them were homogenized in lysis buffer (weight/volume = 1/10). 
The cytokines in sera and colon homogenates were measured by ELISA. (A) IL-6 and IL-17 -in 
sera. (B) IL-6, IL-17, and IL-1β in colon homogenates. (C) Total RNA was isolated from the other 
half of the colon using Trizon reagent. The levels of IL-17, IL-1β, and CXCL2 mRNAs were 
examined using quantitative real-time PCR. Data shown are representatives of two experiments. 
These experiments were performed in collaboration with Honghong Sun and Yunwei Lou. 
*P<0.05; **P<0.01; *** P<0.001. 
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4.2.3 TNFAIP8-deficiency in non-hematopoietic cells exacerbates colitis  
Although enhanced inflammatory responses were detected in the DSS-challenged Tipe-/- 
mice, both hematopoietic and non-hematopoietic compartments could contribute to the 
exacerbated colitis phenotype observed above. To assess which compartment contributes 
directly to the exacerbation of colitis in Tnfaip8-/- mice, we reconstituted sub-lethally irradiated wild 
type and TNFAIP8 knockout mice with bone marrow cells from wild type or knockout mice. After 
recovering for eight weeks, mice were then subjected to five days of DSS treatment followed by 
two days of normal drinking water. As shown in Figure 18, after DSS treatment, the wild type 
mice receiving wild type or Tnfaip8-/- bone marrow cells demonstrated similar changes in body 
weight, disease index, and colon length (Figure 18A, B, and C) indicating that hematopoietic cells 
are not major contributors to the exacerbation of colitis observed in Tnfaip8-/- mice. By contrast, 
when wild type bone marrow cells were injected into Tnfaip8-/- or wild type recipient mice, after 
DSS treatment, Tnfaip8-/- recipients developed more severe colitis than the wild type recipients 
further indicating that the non-hematopoietic compartment plays a major role in the disease 
exacerbation. 
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Figure 18. TNFAIP8 deficiency in non-hematopoietic cells contributes to the enhanced 
colitis in knockout mice 
Bone marrow chimeric mice (n=5) were generated as described previously using wild type (WT) 
and Tnfaip8-/- (Tipe-/-) donor and recipient mice. After the mice were allowed to reconstitute their 
immune systems for 8 weeks, they were treated with DSS for five days, followed by regular 
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drinking water for two days. (A) Body weight loss.  (B) Disease activity index calculated based on 
the degrees of weight loss, stool consistency, and rectal bleeding. (C) Colon length at day 7. Data 
shown are representatives of two experiments. These experiments were performed in 
collaboration with Honghong Sun and Yunwei Lou. *P<0.05; **P<0.01; *** P <0.001. 
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4.2.4 Reduced epithelial integrity and increased bacterial infection in Tnfaip8-/- mice 
TNFAIP8 is expressed in a large number of cell types including colonic epithelial cells. 
The increased mortality in Tnfaip8-/- mice could be explained by increased cell death and/or 
decreased proliferation of colonic epithelial cells during colitis (Araki et al. 2010).To test whether 
TNFAIP8-deficiency affects epithelial cell death and proliferation, epithelial cells were isolated 
from normal and DSS-fed wild type and Tnfaip8-/- colons and cell death was determined by 7-
AAD and Annexin V staining. Live epithelial cells were negative for both 7-AAD and Annexin V 
(Figure 19A). Increased cell death was detected in the Tnfaip8-/- group as compared to WT 
controls. In addition, increased activated caspase 3 staining was observed in the Tnfaip8-/- colons 
(Figure 19B), demonstrating apoptotic cell death. Ki67 is an endogenous marker for cell 
proliferation and histological sections showed significantly reduced Ki67 staining was found in 
DSS-fed Tnfaip8-/- colons compared to those of the wild type colons (Figure 19C and D), 
suggesting that TNFAIP8 protein is required for epithelial cell proliferation after DSS-induced 
damage to the colon.  
The disruption of mucosal barrier following gastrointestinal epithelial cell injury can lead 
to commensal bacterial infection and potent inflammatory responses against them, which is 
believed to be part of the pathogenic mechanisms of DSS-induced colitis (Brown et al. 2013; 
Brestoff & Artis 2013; Honda & Littman 2012). Therefore we checked the bacterial numbers in the 
colons of wild type and Tnfaip8-/- mice with colitis. We found significantly more bacteria in the 
colons of Tnfaip8-/- mice than in WT mice, indicating enhanced dissemination of the commensal 
bacteria (Figure 20). Taken together, increased death of Tnfaip8-/- epithelial cells combined with 
compromised proliferation and the accompanying increase in bacterial infiltration may be 
responsible for the increased mortality in TNFAIP8-deficient mice treated with DSS. 
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Figure 19. TNFAIP8 in gut epithelial cell death and proliferation 
Mice were fed with or without DSS in drinking water for five days followed by regular drinking 
water for two days, and sacrificed. Colons were collected for epithelial cell isolation or 
immunohistochemistry. (A) Epithelial cells from normal water-fed and DSS-fed wild type and 
Tnfaip8-/- colons (n=5) were isolated and cell death was determined by 7AAD and Annexin V 
staining. Colons were washed, fixed, sectioned, and stained for activated caspase 3 or Ki67. (B) 
Bar graph shows numbers of active caspase3+ cells per high power microscopic field. At least six 
fields were counted per sample. (C) Ki67 antibody was used to measure colonic epithelial cell 
proliferation. (D) Bar graph shows percentages of Ki67+ cells in the colons of normal water-fed 
(control) and DSS-fed WT and Tipe-/- mice. These experiments were performed in collaboration 
with Honghong Sun and Yunwei Lou. Scale bar, 100 µm. *P<0.05; **P<0.01; *** p<0.001. 
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Figure 20. Increased bacterial invasion in Tnfaip8-/- colons.  
Wild type and Tnfaip8-/- mice (n=5) were fed with DSS for five days. Mice were then sacrificed and 
had their colons collected. Colon homogenates were diluted and plated on blood agar (A) and 
brain heart infusion (B) plates for determining the bacterial counts. Data shown are 
representatives of two experiments. These experiments were performed in collaboration with 
Yunwei Lou.  *P<0.05. 
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4.3 Discussion 
 
We showed here that Tnfaip8-/- mice are significantly more susceptible to DSS-induced 
colitis. The knockout mice suffered from a greater body weight loss, more severe diarrhea and 
rectal bleeding, and enhanced mortality, indicating a key role of TNFAIP8 in protecting against 
DSS-induced colon damage. Despite the increased activity of immune cells in DSS treated 
knockout mice, TNFAIP8 deficiency in immune cells is not responsible for the increased severity 
of colitis. Consistent with this observation, TNFAIP8 deficiency does not affect T or B cell 
development or function. TNFAIP8 has been reported as an anti-apoptotic molecule in tumor 
cells, but knocking down its expression with RNAi protects thymocytes from glucocorticoid-
mediated apoptosis (Kumar et al. 2004; Woodward et al. 2010). Although the underlying 
mechanism is not very clear, GRE (glucocorticoid response element) transactivation and NF-κB 
transrepression are believed to be involved in multiple myeloma cells (Sharma & Lichtenstein 
2008). Our results did not detect any significant differences in apoptosis of TNFAIP8-deficient 
thymocytes that were treated with dexamethasone (an effective apoptosis-inducing 
glucocorticoid), anti-CD3, or irradiation from wild type cells (data not shown). It is possible that the 
dexamethasone-induced apoptosis occurs through alternate pathways not involving TNFAIP8, it 
is very cell type or condition specific, or alternatively, the RNAi methodology used previously 
affected other closely related proteins that were responsible for the differences in apoptosis.  
The epithelial barrier integrity in the gastrointestinal system is crucial for protecting 
against environmental insults, including toxins, antigens, and microbes (DeMeo et al. 2002). 
Increased epithelial cell death and decreased proliferation is associated with increased severity of 
DSS-induced colitis (Williams et al. 2013). We did observe increased cell death and decreased 
proliferation in Tnfaip8-/- epithelial cells, which is most likely involved with the increased severity of 
colitis in knockout mice. Increased invasion of commensal bacteria through the epithelium is 
associated with heightened inflammatory responses and increased immune cell infiltration during 
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experimentally induced colitis (Xiao et al. 2007). Our results do show increased bacterial counts 
in the colon. Taken together, these results suggest that the loss of integrity of the epithelium may 
have allowed increased bacterial infiltration into the colon that may have served to further 
exacerbate the inflammation and increase the mortality in knockout mice. 
What is most surprising about these results is that TNFAIP8 knockout mice behave so 
differently from TIPE2 knockout mice. TIPE2 knockout mice were protected against DSS induced 
colitis and had enhanced immune cell function (Lou et al. 2014; Wang et al. 2012). The lack of 
differences in the TNFAIP8 immune cells may have been due to compensation by TIPE2, so 
further study may need to be done to elucidate the details. The results from the chimeric 
experiment, however, suggest that the immune cells are not the primary contributing factor to the 
differences observed. It is interesting to note that the resistance of TIPE2 knockout mice to DSS 
induced colitis was determined to be the immune cells by the same kind of chimeric experiment 
(Lou et al. 2014). The epithelium of TNFAIP8 knockout mice was more sensitive to death in DSS 
treated mice so the differences in mortality are most likely due to the differences in epithelial cell 
survival. TIPE2 appears to have pro-apoptotic and inflammatory properties, that when knocked 
out may have been beneficial in reducing inflammation and prevent cell death in the colonic 
epithelium  (Gus-Brautbar et al. 2012; Sun et al. 2008). Reduced damage to the epithelial layer of 
TIPE2 knockout animals may have also been responsible for the decreased numbers of bacteria 
in the colon in DSS treated mice. TNFAIP8, however, has anti-apoptotic properties, and we were 
unable to observe any increases in cell death from dexamethasone treatment (Kumar et al. 
2004). The protective effect of TNFAIP8 may have been necessary to sustain the integrity of the 
epithelial barrier to protect the mice from the bacterial and subsequent leukocyte infiltration. So 
despite the high homology shared between TNFAIP8 and TIPE2, they could potential serve as 
antagonists to one another during cell death resulting opposite phenotypes in DSS treated 
knockout mice.  
Whether or not TNFAIP8 and TIPE2 share the same role, or function in a balance of 
opposing effects, it is apparent the TNFAIP8 is highly relevant to experimentally induced colitis 
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and inflammation. Its effect on cell death is widely supported in cancer literature, and it is not 
surprising that regulating cell death is also highly relevant to the field of inflammation. TNFAIP8 
may not yet have a finely defined role in immune cells, but its role in the non-immune system may 
be just as relevant to inflammation and indeed cancer. Cancer and inflammation are closely 
linked mechanisms and investigating TNFAIP8’s role in inflammation may prove to be crucially 
important in both the treatment and diagnosis of a wide variety of inflammatory diseases and 
cancer. 
 60 
Chapter 5 – Cell death and infection 
 
5.1 Introduction 
 
Listeria monocytogenes is an intracellular gram-positive bacterium that infects a number 
of cell types including hepatocytes, neurons, and immune cells. Immune cell-mediated apoptosis 
of L. monocytogenes-infected cells such as hepatocytes is important for resolving infection 
(Vázquez-Boland et al. 2001). In addition, cell death and proliferation of colonic epithelium is 
considered important in regulating the severity of DSS-induced colitis in mice (Araki et al. 2010). 
Since no differences in immune cell function were detected, we now hypothesize that the 
resistance to lethal L. monocytogenes infection in TNFAIP8 knockout mice and the increased 
susceptibility to DSS-induced colitis are the result of the altered function in non-immune cells. 
TNFAIP8 knockout epithelial cells appear to be sensitized to cell death and have reduced 
proliferation following DSS treatment. This is supported in cancer literature where TNFAIP8 has 
been reported to protect cancer cells from TNFα-induced apoptosis and overexpression in tumor 
cell lines also enhanced proliferation and migration (Kumar et al. 2000; Kumar et al. 2004). Both 
disease models in TNFAIP8 knockout mice can be potential explained by the enhanced cell death 
in non-immune cells.  
An alternative explanation for increased resistance to lethal L. monocytogenes infection 
is that TNFAIP8 knockout host cells are resistant to invasion by the bacteria. A few TNFAIP8 
interacting partners have been identified, including activated Gαi3 and Karyopherin α2, and 
TIPE2 has been reported to interact with RAC1 and to protect against lethal L. monocytogenes 
and Staphylococcus aureus infection (Laliberté et al. 2010; Wang et al. 2012). RAC1 and other 
RHO GTPases are considered important in L. monocytogenes internalization into host cells 
(Ireton et al. 2014). We sought to determine the importance of RAC1 to the function of TNFAIP8 
 61 
and whether there is an association or interaction between these two molecules that could 
explain L. monocytogenes infection in TNFAIP8 knockout mice.  
To investigate these hypotheses, we created TNFAIP8 knockdown cell lines to test 
difference in cell death and proliferation, L monocytogenes infection, and to determine the 
molecular pathways affected by TNFAIP8 deficiency. 
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5.2 Results 
 
5.2.1 TNFAIP8 knockdown cells are sensitized to cell death 
Since differences in immune function did not adequately explain the resistance to lethal 
L. monocytogenes infection in TNFAIP8-knockout mice, we investigated the roles of TNFAIP8 in 
non-immune cells involved in bacterial infection. Hepatocytes are a major target of L. 
monocytogenes infection, so we generated TNFAIP8 knockdown Hepa1-6 murine liver cells.  
Using a lentiviral vector expressing either a scrambled shRNA sequence or sequences targeting 
the Tnfaip8 gene, we created several knockdown cell lines and determined the protein levels of 
TNFAIP8 and AKT (Figure 21A). We found that shRNA-tnfaip8-1 (SH1) was a nearly complete 
knockdown, with increased AKT phosphorylation at Serine 473. AKT phosphorylation at Serine 
473 is regulated by MTORC2 and PI3K and is important in regulating apoptotic cell death, and 
PI3K itself is important in L. monocytogenes cell invasion (Hatano & Brenner 2001; Jiwani et al. 
2012).  In addition, we generated TNFAIP8 knockdown NIH3T3 cells to make sure that the cell 
death phenotypes observed are not isolated to the HEPA1-6 cell line and confirmed it by real time 
PCR (Figure 21B). We next attempted to confirm reports that TNFAIP8 is a negative regulator of 
apoptosis and challenged the Hepa1-6 or NIH3T3 cells with either TNFα and cycloheximide or 
DSS, respectively, and found increased sensitivity in the knockdown cell lines to cell death 
(Figure 22). Finally, we tested whether proliferation was affected in knockdown cells and we 
found that TNFAIP8 knockdown cells had a minor increase in doubling time (Figure 23). 
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Figure 21. Hepa1-6 and NIH3T3 TNFAIP8 knockdowns 
Hepa1-6 and NIH3T3 knockdown cells were generated using the pLKO.1 lentiviral vector to 
express either a scrambled shRNA (Scr) or one of the two antisense sequences targeting 
TNFΑIP8 (SH1 and SH2). (A) Western blot was performed for the indicated proteins in the lysates 
of untransfected control (UT) and shRNA-scramble (Scr) or shRNA-Tnfaip8 (SH1 and SH2) 
Hepa1-6 cells. (B) RT-PCR analysis was used to determine the effectiveness of the knockdown in 
NIH3T3 cells. 
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Figure 22. Knockdown cells are sensitized to cell death 
(A) Hepa1-6 knockdown and control cell lines were untreated (NT) or treated with 5 ng/ml of 
TNFα (TNF) and 20 ng/ml of cycloheximide (CHX) for 6 hours. Cell death was determined by flow 
cytometry after Annexin V and 7-AAD staining. (B) NIH3T3 cells were treated with 3% DSS in 
culture medium for 16 hours. Cells were then collected and cell death was represented by 
Annexin V staining.  The results are representative of at least two independent experiments. ** P 
< 0.01 
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Figure 23. Minor difference in proliferation of knockdown cells 
(A). 2.5x104 Hepa1-6 scramble (Scr) and TNFAIP8 knockdown (SH1) cells were plated and 
counted daily. (B) Doubling time was calculated using four independent experiments. * P < 0.05 
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5.2.2 TNFAIP8 knockdown cells are sensitized to infection and death by L. monocytogenes 
Next we tested whether L. monocytogenes invasion of Hepa1-6 cells was affected by 
TNFAIP8 depletion. After allowing the bacteria to invade cells for 1 hour, we found that the 
knockdown cells had reduced bacterial burden, with or without TNFα treatment, and TNFα did not 
provide any protective effect against bacterial invasion (Figure 24A). TNFα is important in 
protecting mice against many bacterial pathogens. Hepatocytes produce TNFα upon exposure to 
L. monocytogenes, and its depletion sensitizes mice to death by L. monocytogenes (Santos et al. 
2005; Miura et al. 2000).   Next we tested whether TNFAIP8 knockdown had an effect on L. 
monocytogenes -induced cell death. We incubated the cells with L. monocytogenes overnight 
with or without TNFα and found that the TNFAIP8 knockdown cells showed enhanced sensitivity 
towards cell death only when treated with both L. monocytogenes and TNFα (Figure 24B). Our 
results suggest that the resistance to lethal L. monocytogenes infection in mice could be caused 
by the resistance of host cells to bacterial invasion and increased sensitivity to cell death 
following infection, thereby reducing bacterial load in the organism. L. monocytogenes evades the 
host immune system by hiding within cells where phagocytes are unable to reach them. If the 
host cells are more difficult to infect and are more susceptible to apoptosis, phagocytes will have 
greater access to the pathogen and bacterial reproduction may be sufficiently impeded to confer 
a survival advantage to the host. 
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Figure 24. Listeria infection was reduced in TNFAIP8 knockdown cells and cell death was 
increased 
(A) L. monocytogenes infection of control and TNFΑIP8 knockdown Hepa1-6 cells was measured 
in a colony formation assay. Cells were infected with 50 MOI of L. monocytogenes for 1 hour with 
50 ng/ml of TNFα or without (NT). Cells were washed and then treated with 150 μg/ml 
Gentamycin for 30 minutes to kill extracellular bacteria before being lysed to release the 
intracellular bacteria. (B) Hepa1-6 TNFAIP8 knockdown and control cells were challenged with L. 
monocytogenes  (L) at 60 MOI with or without 50 ng/ml of TNFα (T) for 16 hours. Death was 
quantified by flow cytometry after Annexin V staining. The results are representative of at least 
two independent experiments. N.S., not significant; ** P < 0.01; *** P < 0.001. 
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5.2.3 TNFAIP8 associates with RAC1 with a higher affinity towards active RAC1-GTP in vitro.  
RAC1 is an important regulator of cell death following TNFα stimulation, and TNFAIP8 
has been found to protect against TNFα-induced cell death (Jin et al. 2008; Laliberté et al. 2010; 
Kumar et al. 2004; Kumar et al. 2000; Kim et al. 2007). RAC1 has also been found to regulate L. 
monocytogenes invasion into endothelial cells (Wang et al. 2012; Schmeck et al. 2006). So we 
tested whether Flag-tagged TNFAIP8 associates with HA-tagged RAC1by co-transfection of their 
corresponding plasmids. We immunoprecipitated Flag-tagged TNFAIP8 and blotted for HA and 
found that TNFAIP8 and RAC1 co-immunoprecipitated (Figure 25A). We then tested whether this 
interaction was dependent on a particular region of RAC1. We created several HA-tagged Rac1 
mutants and transfected them into 293T cells along with Flag-tagged TNFAIP8. We pulled down 
Flag and blotted for HA and found that RAC1 association was impaired with the Δ162-192 RAC1 
mutant, which lacks the polybasic region (PBR) and CAAX motif (Figure 25A).  The PBR is critical 
for RAC1 interaction with certain proteins and proper cellular localization (Modha et al. 2008; 
Williams 2003). The CAAX motif is responsible for post-translational modification and is crucial for 
the proper function of RAC1 (Casey et al. 1989; Kreck et al. 1994). We then tested whether 
TNFAIP8 can associate with endogenous RAC1 by transfecting 293T cells with a plasmid 
encoding Flag-tagged TNFAIP8 and immunoprecipitating cell lysates with anti-RAC1 antibody or 
control IG and blotted for Flag- TNFAIP8 (Figure 25B). We found that plasmid expressed 
TNFAIP8 appeared to co-immunoprecipitated with endogenous RAC1 although conclusions 
about an endogenous interaction cannot yet be reached. 
To test whether TNFAIP8-RAC1 interaction is dependent on the activation status of 
RAC1, we loaded 293T lysate expressing Myc-tagged RAC1 and Flag-tagged TNFAIP8 with non-
hydrolyzable forms of GTP (GTPγS) and GDP (GDPβS). We found increased TNFAIP8 
association with GTPγS loaded RAC1, suggesting that TNFAIP8 preferentially associates with 
the active form of RAC1 (Figure 26). These results demonstrate that TNFAIP8 associates with 
active RAC1 and that this association may be responsible for the TNFAIP8 effect in L. 
monocytogenes infection.
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Figure 25. Overexpressed TNFAIP8 associates with RAC1 
(A) HA-tagged RAC1 mutants were co-expressed with Flag-tagged TNFAIP8 in 293T cells, and 
IP was performed using anti-Flag. Western blots were developed using anti-HA antibody to 
identify RAC1 mutants co-immunoprecipitated with TNFAIP8. (B) 293T cells were transfected 
with the pRK5 expression plasmids containing Flag-tagged TNFΑIP8. Anti-RAC1 antibody or 
mouse IG was used to immunoprecipitate the Flag-tagged TNFAIP8 and Western blotting was 
performed using the indicated antibodies. The results are representative of at least two 
independent experiments. 
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Figure 26.TNFAIP8 has a stronger association with GTPγS loaded RAC1 
293T cells were cotransfected with Flag-tagged TNFAIP8 and Myc-tagged RAC1 or empty pRK5 
vector. Total cell lysates were then treated with or without GTPγS or GDPβS, and anti-Myc 
antibody was used to immunoprecipitate RAC1. TNFAIP8 and RAC1 were determined by 
Western blotting. The results are representative of at least two independent experiments. 
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5.2.4 TNFAIP8 affects RAC1 activity  
To test whether there is a difference in RAC1 activation, PAK-GST beads were used to 
pull down RAC1. PAK only binds to active RAC1-GTP and is routinely used to assay for RAC1 
activity. Knockdown and control cells were stimulated with TNFα for 5 minutes and the amount of 
RAC1 pulled down with PAK-GST beads was compared (Figure 27A). We found dysregulated 
RAC1 activation in TNFAIP8 knockdown cells, with higher basal levels of RAC1-GTP, but limited 
induction following TNFα stimulation. Next we checked whether there were any differences in 
RAC1 trafficking to the membrane and found impaired RAC1 translocation following TNFα 
stimulation (Figure 27B). In control cells, TNFAIP8 seemed to primarily localize to the cytosol, but 
surprisingly, there was more TNFAIP8 on the membrane than in the cytosol in the knockdown 
cells.  
We tested whether the differences in knockdown cell death are RAC1-dependent by 
transfecting cells with plasmids expressing constitutively active RAC1-61L or inactive RAC1-17N 
and treated them with TNFα and cycloheximide (CHX) (Figure 28A). We found that the dominant 
negative mutant partially rescued cell death in both cell lines while the constitutively active mutant 
greatly sensitized the control cells to death, but had a more limited effect on the knockdown cells 
(Figure 28B). 
We then attempted to determine a working concentration of RAC1 inhibitor that would 
eliminate the differences in the amount of active RAC1 at basal levels without completely 
inhibiting RAC1 activity. We pretreated TNFAIP8 knockdown and control cells with varying 
concentrations of the inhibitor and performed a PAK-GST pull down. We found that the lowest 
dose tested was effective at reducing the differences at basal levels (Figure 29A). To investigate 
the relevance of RAC1 signaling to L. monocytogenes invasion of the knockdown cells and 
whether the RAC1 inhibitor will have an effect, we infected TNFAIP8 knockdown and control cells 
with L. monocytogenes, with or without RAC1 inhibitor pretreatment. We found that the inhibitor 
protected both knockdown and control cell lines from bacterial invasion, and negated any 
differences between the cell lines at the highest concentration (Figure 29B).   
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Our results suggest that RAC1 activation is dysregulated in TNFAIP8-deficient cells, 
which likely contributes to the altered response to L. monocytogenes infection and cell death, but 
the exact mechanism is still unknown.  
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Figure 27. Impaired RAC1 activation in TNFAIP8 knockdown cells 
(A) The levels of RAC1-GTP was determined by a PAK-GST pull down assay for control and 
TNFAIP8 knockdown Hepa1-6 cells stimulated with or without 50 ng/ml of TNFα for 5 minutes. 
(B) Control and TNFAIP8 knockdown Hepa1-6 cells were stimulated with 50 ng/ml of TNFα for 0, 
2, 5, or 15 minutes. Lysates were fractionated into membrane [M] and cytoplasmic [C] portions, 
and TNFAIP8, RAC1, and actin were detected by Western blot. 
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Figure 28. RAC1 mutants did not rescue cell death in TNFAIP8 knockdown cells 
(A) Control and TNFAIP8 knockdown Hepa1-6 cells were transiently transfected with pEGFP 
vectors containing either the EGFP cDNA alone [E], or EGFP plus RAC1-17N [R-] or RAC1-61L 
[R+] cDNAs. Cells were treated with 5 ng/ml of TNFα and 20 ng/ml of cycloheximide for 6 hours. 
EGFP positive cells were gated by flow cytometry and cell death was detected by Annexin V and 
7-AAD staining. (B) Fold difference in cell death is shown relative to EGFP control. The results 
are representative of at least two independent experiments. * P < 0.05; ** P < 0.01 
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Figure 29. RAC1 inhibition reduced bacterial infection 
 (A) The levels of RAC1-GTP was determined by a PAK-GST pull down assay for control (Wt) 
and TNFAIP8 knockdown (Kd) Hepa1-6 cells treated with the indicated amounts of RAC1 
inhibitor II for 3 hours. (B) Hepa1-6 control (Scr) and TNFAIP8 knockdown (SH1) cells were 
infected with 50 MOI of L. Monocytogenes after no pretreatment (UT) or pretreatment with 
indicated amounts of RAC1 inhibitor II (RI) for 3 hours before infection. 
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5.3 Discussion 
  
The role of TNFAIP8 in cell death appears to be condition-dependent.  In most tumor 
cells, a protective effect of TNFAIP8 is reported; however in thymocytes, TNFΑIP8 has been 
found to promote gluococorticoid-induced apoptosis (Woodward et al. 2010). The molecular 
pathways of cell death that are regulated by TNFAIP8 are still largely unknown. Previous work 
suggests that TNFAIP8 protects against death through its ‘death effector domain (DED)’, but that 
hypothesis has been largely debunked by the structural analysis of TIPE2, which revealed a 
novel fold instead of a DED domain (Kumar et al. 2004; Zhang et al. 2009). Others have 
suggested that TNFAIP8 works through Gα(i) proteins, and have shown that TNFAIP8 is 
important for the function of dopamine-D2short receptors in protecting against TNFα-induced cell 
death (Laliberté et al. 2010). Recently, TIPE1, another TNFAIP8 family member, has been 
implicated in activating mTOR to protect against oxidative stress in dopamine neurons by 
blocking autophagy (Choi et al. 2010).  The mTOR protein itself plays an important role in 
promoting cancer, protecting against cell death, and increasing susceptibility to lethal L. 
monocytogenes infection, and has also been found to be regulated by the small GTPase RAC1 
(Strimpakos et al. 2009; Weichhart et al. 2008; Saci et al. 2011). We show here that TNFAIP8 
associates with RAC1 and regulates TNFα-induced cell death and L. monocytogenes infection in 
Hepa1-6 cells. We propose that it does so by regulating RAC1 signaling. 
We observed an increase in phosphorylated AKT at serine 473 in TNFAIP8 knockdown 
cells, suggesting that mTOR may also be regulated by TNFAIP8. As AKT is important in cell 
survival and proliferation, we also examined proliferation in TNFAIP8 knockdown Hepa1-6 cells 
(Zheng et al. 2014; Kim & Chung 2002). Proliferation was slightly increased, which is supported 
by the AKT results, but the difference was very slight and may have been due to random chance 
and as a result, an artifact. TNFAIP8’s effect on proliferation may be more pronounced in primary 
cells, as in the knockout epithelium, which actually showed the opposite phenotype in Chapter 4. 
This discrepancy is likely due to differences in cell type or conditions, or from the limitations of the 
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knockdown methodology. Similar to the observed increase in epithelial cell death to DSS induced 
colitis, TNFAIP8 knockdown cells were more susceptible to TNFα induced-death as described 
previously in cancer cells. Increased AKT phosphorylation did not predict susceptibility and is 
likely unrelated.  
The knockdown cells, while more susceptible to apoptosis, were resistant to infection by 
L. monocytogenes. In addition, while there was no increase in cell death following incubation with 
the bacteria compared to control cells, TNFα greatly stimulated cell death in knockdown cells but 
not in controls. Intracellular bacterial pathogens such as L. monocytogenes, Shigella flexneri, and 
Salmonella typhimurium have been shown to enhance TNFα-induced cell death in L cells 
(Klimpel et al. 1990). This suggests that the knockdown cells are sensitized to TNFα-induced cell 
death following bacterial infection, and it is supported by published data reporting the importance 
of TNFα function for controlling lethal L. monocytogenes infection (Carr et al. 2011; Abreu et al. 
2013; Peña-Sagredo et al. 2008). Literature on the pathogenesis of L monocytogenes report that 
its entire lifecycle can occur within host cells and that the bacteria can spread directly to 
neighboring cells through the formation of pseudopods by the infected cells, and that the 
apoptotic clearance and isolation of infected hepatocytes by immune cells is important in 
preventing the spread of the infection (Vázquez-Boland et al. 2001). This led us to hypothesize 
that TNFAIP8 knockout mice were more resistant to lethal L. monocytogenes infection than wild 
type mice due to a combined effect of reduced bacterial cell invasion and a heightened sensitivity 
to cell death by inflammatory cytokines of the host cells that helped stall a productive bacterial 
infection sufficiently to give the knockout mice a survival advantage. 
RAC1 has been implicated in regulating mTOR complexes by its interaction with 
mTORC1 and mTORC2 proteins (Saci et al. 2011). In addition, TIPE2 has been found to 
associate with RAC1 (Wang et al. 2012). This led us to investigate whether TNFAIP8 effector 
functions are dependent on RAC1 signaling because both RAC1 and mTOR are implicated in L. 
monocytogenes invasion of cells and apoptosis as well as apoptosis in intestinal epithelium 
(Weichhart et al. 2008; Schmeck et al. 2006; Jiwani et al. 2012; Jin et al. 2006). We showed that 
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TNFAIP8 associates with RAC1 by co-immunoprecipitation of plasmid expressed TNFAIP8 with 
endogenous RAC1. We were forced to use transiently expressed TNFAIP8 tagged with the Flag 
peptide due to the very weak binding affinity of the commercial TNFAIP8 antibodies. There were 
difficulties in the immunoprecipitation and visualization of the endogenous RAC1 due to its 
proximity to the small IGG chain, so it is difficult to come to a definitive conclusion of TNFAIP’s 
endogenous interaction with RAC1, and additional work needs to be done to show that this 
interaction is not an artifact of the over-expression system. We further found that the TNFAIP8 
association is dependent on the C-terminus of RAC1, which contains the PBR and CAAX motif. 
These two regions are responsible for protein interactions, membrane localization signaling, and 
post-translational modifications. Our finding that the association is dependent on whether RAC1 
is primed with GTP or GDP, suggests that RAC1 interaction with TNFAIP8 is enhanced with 
RAC1 activation.  
After testing several conditions using TNFAIP8 knockdown cells, we were able to 
conclude that RAC1 is an important mediator of TNFα-induced cell death but we were unable to 
determine precisely how or whether RAC1 is directly involved with TNFAIP8 during these 
processes. By introducing the dominant negative mutant of RAC1, TNFα-induced cell death in 
TNFAIP8 knockdown cells is partially rescued. Furthermore, the constitutively active mutant had 
a stronger effect on the control cells than they did on the knockdown cells, presumably because 
the RAC1 signaling was already heightened in knockdown cells. We observed increased RAC1-
GTP at basal levels in knockdown cells and enrichment of TNFAIP8 in the membrane fraction 
when compared to the controls. The localization of TNFAIP8 in knockdown cells suggests that the 
membrane association is crucial for proper cell function and that it may be related to the 
increased RAC1 activation. This led us to the hypothesis that TNFAIP8 knockdown cells are more 
susceptible to TNFα-induced cell death because there is insufficient TNFAIP8 present to inhibit 
RAC1.  
Bacterial entry into knockdown cells is inhibited in spite of increased RAC1 activation and 
reports that RAC1 activation is necessary for bacterial entry (da Silva et al. 2012; Schmeck et al. 
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2006). We used a cell permeant RAC1 inhibitor (Z62954982) that functions by blocking the RAC1 
interaction with several of its activating GEFs (Ferri et al. 2009). We attempted to titrate the RAC1 
inhibitor to a minimal concentration that would reduce the amount of activated RAC1 in TNFAIP8 
knockdown cells to the amount present in control cells at basal conditions. The purpose was to 
find a concentration that would not impede bacterial entry but be sufficient to test the role of 
RAC1 in L. monocytogenes invasion of TNFAIP8 knockdown cells. A surprising result was that 
the Rac1 inhibitor did not reduce the amount of basal RAC1 pulled down. A possible explanation 
may be that alternative pathways are activating RAC1 that are stimulated by the inactivation of 
the classical RAC1 pathway. A more likely explanation is that the inhibitor is more effective at 
blocking activation as opposed to basal activity states, and published literature for Z62954982 still 
detects RAC1-GTP at basal levels, and the closely related NSC23766 RAC1 inhibitor is also only 
effective at inhibiting RAC1 activation but not inhibiting basal states (Yu et al. 2012; Veluthakal et 
al. 2009; Yuan et al. 2010). The actual effectiveness of the inhibitor concentrations may need to 
be determined by attempting to stimulate RAC1 activation. The RAC1 inhibitor did, however, 
inhibit bacterial invasion of both knockdown and control cells and eliminated the differences in 
bacterial counts, suggesting that RAC1 may be responsible for the differences in bacterial 
invasion. A possible explanation for the reduced bacterial invasion of knockdown cells in the face 
of elevated RAC1 activation is that RAC1 is activated nonspecifically throughout the cellular 
membrane in TNFAIP8 deficient cells, increasing ROS production and activating molecular 
pathways that do not require localized activation. Functions that require localized activation, like 
the internalization of a L. monocytogenes cell on a host membrane, may be inhibited because 
there is too much background RAC1 activation to efficiently recruit the required proteins to a 
specific location and internalize the bacterium. An alternative explanation is that infected 
TNFAIP8 knockdown cells are dying rapidly, reducing the total number of bacteria protected from 
the gentamycin treatment. This explanation, however, seems unlikely due to the short incubation 
time with L. monocytogenes for the infection experiments, and that no difference in death induced 
by L. monocytogenes was observed after 24 hours compared to control cells.  
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In this chapter, we learned that TNFAIP8 regulates cell death and L monocytogenes 
infection in Hepa1-6 cells, and that altered RAC1 function may be responsible. Understanding the 
molecular interaction of TNFAIP8 with RAC1 is important in identifying therapeutic targets for 
treating a wide variety of diseases, including inflammatory disease, bacterial infections and 
cancer, and it should be studied in the future.  
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Chapter 6 – Discussion and future directions 
 
Listeria monocytogenes pathogenesis is dependent on a number of factors related to 
both the immune and non-immune systems. A cascade of TNFα and other cytokines is released 
by infected cells to trigger an immune response to the infected liver (Pamer 2004; Vázquez-
Boland et al. 2001; Rogers et al. 1996; Santos et al. 2005). If the pathogen is not controlled by 
the immune system, L. monocytogenes will escape to other organs and the host can die of 
sepsis. Protecting immune cells from death has been found to be an important aspect in 
preventing lethal L. monocytogenes infection (Zheng et al. 2004; Gurung et al. 2011). But 
promoting cell death in hepatocytes or blocking cellular invasion might be equally important for 
the survival of the organism (dos Santos et al. 2011; Santos et al. 2005; Schmeck et al. 2006). In 
addition, cell death in the colonic epithelium during colitis can exacerbate the inflammatory 
response and increase susceptibility to infection (Araki et al. 2010; Kassam et al. 2014). The 
epithelial barrier integrity in the gastrointestinal system is crucial for protecting against 
environmental insults, including toxins, antigens, and microbes (DeMeo et al. 2002). Increased 
epithelial cell death and decreased proliferation is associated with increased severity of DSS-
induced colitis in mice (Williams et al. 2013). 
In chapter 3 we found that TNFAIP8 knockout mice were resistant to lethal L. 
monocytogenes infection, and that this resistance is likely due to the non-immune system. In 
chapter 4 we found that the TNFAIP8 knockout mice were more susceptible to DSS induced 
colitis and once again that this was likely due to the non-immune system. More specifically, we 
determined that it was likely due to the increased death and reduced proliferation of the epithelial 
cells in the colon. Finally, in chapter 5 we showed that TNFAIP8 regulates cell death and Listeria 
invasion into Hepa1-6 cells and that these processes may be due to the impaired function of 
RAC1 in TNFAIP8 deficient cells. This led us to the conclusion that the phenotypes in the two 
disease models can be explained by a common mechanism in inflammation. We therefore 
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hypothesize that TNFAIP8 is a novel regulator of inflammation, and that the phenotypes observed 
in the disease models stem from differences in cell death and bacterial invasion into non-immune 
cells (Figure 30). 
Here, we propose that TNFAP8 regulates TNFα-induced cell death by its inhibition of 
RAC1 (Figure 31). The TNFα signaling cascade activates pro-death pathways through caspase 
cleavage and ROS production by the NAPDH oxidase complex, and pro-survival pathways 
through the activation of the NF- κB transcription factor. Inhibition of RAC1 and the associated 
NADPH oxidase activation has been documented to protect cells against both apoptotic and 
necrotic cell death following TNFα stimulation (Jin et al. 2008; Kim et al. 2007). TNFAIP8 
expression is reported to be up-regulated by TNFα signaling through NF-κB (Kumar et al. 2000; 
You et al. 2001). Our findings suggest that NF- κB can protect against cell death by preventing 
ROS production through RAC1 inhibition by the expression of TNFAIP8. Additional work needs to 
be done to confirm this hypothesis and investigate the other downstream effects of a TNFAIP8 
regulated RAC1 pathway, including F-actin polymerization and ROS production. In addition, 
TNFAIP8 association with other RHO GTPases should also be explored. 
We also propose that RAC1 regulation by TNFAIP8 is important for L. monocytogenes 
invasion of host cells. L. monocytogenes Internalin A and B surface proteins bind to MET (also 
known as the hepatocyte growth factor receptor), β-integrin and E-cadherin receptors to activate 
RAC1 and induce F-actin cytoskeletal remodeling that allow for bacterial entry into the cells 
(Figure 32) (da Silva et al. 2012). We hypothesize that TNFAIP8 functions to reduce background 
RAC1 activation, allowing for precise control of RAC1 signaling. Insufficient TNFAIP8 may 
interfere with this aspect of bacterial infection by preventing localized RAC1 signaling at the site 
of bacterial entry thus preventing the recruitment of F-actin and inhibiting bacterial internalization 
(Figure 33). This model needs to be fully investigated and the extent of the RAC1 dysfunction in 
bacterial invasion of TNFAIP8 deficient cells needs to be scrutinized. Double knockout mice for 
TNFAIP8 with a conditional RAC1 knockout in non-lymphoid tissues may be used to investigate 
the importance of RAC1 in TNFAIP8 regulation of listeriosis. RAC1 knockout mice should be 
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resistant to infection, but if a difference is observed between the TNFAIP8 and RAC1 double 
knockout mice, and single RAC1 knockout mice, then it is possible that TNFAIP8 is part of an 
alternative pathway regulating bacterial invasion and cell death in mice. This can be tested in vitro 
using RAC1 inhibitors and mutants (as has been partially explored in chapter 5), but the results 
are not as conclusive due to the artificial nature of the systems. 
Contrary to the differences observed with L. monocytogenes invasion of the Hepa 1-6 cell 
lines, phagocytosis by TNFAIP8 knockout bone marrow-derived macrophages showed no 
abnormalities. One possible explanation is that the lack of TNFAIP8 in the knockout 
macrophages is compensated by the presence of TIPE2. TIPE2 protein is undetectable in Hepa 
1-6 cells (data not shown), but is expressed in macrophages where it regulates phagocytosis 
(Wang et al. 2012). A second potential explanation is that the molecular mechanism for 
phagocytosis of L. monocytogenes in macrophages is sufficiently different from the endocytosis 
of L. monocytogenes in Hepa 1-6 cells that TNFAIP8 deficiency can affect one but not the other. 
There are several different forms of endocytosis, and L. monocytogenes  has been shown to take 
advantage of Clathrin-dependent MET receptor-mediated endocytosis to gain entry into the cell 
(Veiga & Cossart 2005). 
Perhaps the most surprising result from this work is the contrast in the function of 
TNFAIP8 and its closely related family member, TIPE2. TIPE2 is a novel regulator of 
inflammation and studies have reported its effects on migration, phagocytosis and oxidative burst 
in immune cells, resistance to bacterial infections, inflammation, and resistance to experimental 
colitis (Sun et al. 2008; Wang et al. 2012; Gus-Brautbar et al. 2012; Lou et al. 2014). While both 
TNFAIP8 and TIPE2 knockout mice are resistant to lethal L. monocytogenesis infection, TNFAIP8 
knockout immune cells do not exhibit any detectable differences in phagocytosis, cytokine 
production or chemotaxis, and TNFAIP8 knockout mice do not show any differences in 
susceptibility to lethal Staphylococcus aureus infection. TNFAIP8 knockout mice are also more 
susceptible to DSS-induced colitis, unlike TIPE2 knockout mice, which are resistant. In addition, 
TIPE2 bone marrow chimeras suggest that the immune cells as the cause of the resistance of 
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TIPE2 knockout mice to DSS-induced colitis (Lou et al. 2014). Differences in immune function 
may be due to compensation of the lack of TNFAIP8 with TIPE2, and their contrasting effects 
may be due to different expression profiles. Whereas TNFAIP8 is widely expressed throughout 
the organism, TIPE2 is largely limited to immune cells, and my study here does point to non-
immune cells as the culprit to the different outcomes of the disease models in TNFAIP8 knockout 
mice. On the other hand, TIPE2 is reported to be a promoter of cell death, the opposite of 
TNFAIP8. These two proteins may potentially function as antagonists to one another to maintain 
homeostasis within the organism, but this hypothesis needs considerable study and review. Then 
there are the lesser known TNFAIP8 family members, TIPE1 and TIPE3, which may have other 
contrasting roles that have yet to be fully understood. What is known for certain, however, is that 
TNFAIP8 is different from TIPE2, and that both of these molecules are important to inflammatory 
diseases, and further study is needed on the entire TNFAIP8 family. 
The work presented here attempts to describe the importance of TNFAIP8 in 
inflammation and hopes that understanding the biology might aid studies in treating or abrogating 
inflammation in patients. Autoimmune diseases are very common and are estimated to occur in 
7.6%-9.4% of the population and predispose the patients to certain cancers (Cooper et al. 2009; 
Mantovani & Balkwill 2006). Treatments typically involve anti-inflammatory drugs, immune-
suppressive glucocorticoid steroids, non-steroidal drugs, hormone therapy, intravenous 
immunoglobulin injections, and novel treatments including antibody depletion of inflammatory 
cytokines such as TNFα (Dinarello 2010; Danieli et al. 2014; Willrich et al. 2014). Furthermore, 
the treatment of these disorders often comes at a price of increased susceptibility to microbial 
infections (Kassam et al. 2014; Abreu et al. 2013). Understanding these processes is necessary 
to develop novel, more effective and safer treatment methods and it requires the dissection of the 
molecular pathways involved. What I have uncovered in this study is a novel regulator of 
inflammation that was once thought to be predominantly important in cancer. I discovered that 
TNFAIP8 seems to regulate inflammation through non-immune cells and it is important to note 
that non-immune cells have crucial roles in the inflammatory response. Non-hematopoietic 
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derived cells such as intestinal epithelial and stromal cells have been shown to be important in 
regulating inflammation, possibly through the NF-κB pathway, to maintain a healthy immune 
homeostasis within the mucosa of the intestines that when disrupted could lead to inflammation 
or increased susceptibility to infection (Zaph et al. 2007; Pasparakis 2012; Owens & Simmons 
2013). TNFAIP8, an NF-κB regulated protein, could potentially explain how and why these 
particular cells are important to inflammation, and lead to further understanding of the impact of 
other non-immune cells to inflammatory diseases (You et al. 2001). New potential regulators of 
the inflammatory response, like TNFAIP8, should be thoroughly investigated because they may 
hold the key to developing novel drugs and treatments for inflammatory diseases, infectious 
diseases, and even cancers worldwide.  
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Figure 30. TNFAIP8 project summary 
TNFAIP8 is a novel regulator of inflammation. It affects the outcome of two inflammatory diseases 
in TNFAIP knockout mice, increasing resistance to lethal Listeria monocytogenes infection and 
increasing susceptibility to DSS-induced experimental colitis. Both of these effects appear to be 
due to differences in the non-immune system, which was investigated in TNFAIP8 knockdown 
cell lines. It was found that these cell lines were resistant to infection and had increased 
susceptibility to cell death and that these effects may be due to impaired RAC1 activity. The 
increased cell death likely lead to exacerbated colitis in knockout mice, and the increased cell 
death and decreased susceptibility to infection by L. monocytogenes probably resulted in 
increased resistance to lethal Listeria infection in knockout mice. 
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Figure 31. Model of TNFAIP8 molecular function in cell death 
TNFα activates the tumor necrosis factor receptor (TNFR), which results in RAC1 and NF-κB 
activation. RAC1 then activates the NAPDH oxidase complex to generate reactive oxygen 
species (ROS) that promote cell death. The NF-κB transcription factor promotes TNFAIP8 
expression to inhibit RAC1 activation and protect against cell death. 
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Figure 32. Model of RAC1 molecular function during Listerial cell invasion 
(A) Listeria Internalin A and B (InlA, InlB) surface proteins bind to host cell receptors to activate 
local cytoskeletal remodeling to allow L. monocytogenes to internalize itself into the host. RAC1 
activation of the ARP2/3 complex is responsible for actin polymerization that engulfs the bacteria 
on the cell membrane, thus allowing entry into the cell.  
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Figure 33. Model of TNFAIP8 role in host cell invasion by L. monocytogeneses 
TNFAIP8 inhibits nonspecific RAC1 activation in the background of normal cells. Listeria 
attachment to the surface of wild type cells (WT) precisely activates RAC1 on the surface of the 
membrane allowing efficient entry. TNFAIP8 knockdown cells (KD) have high background levels 
of RAC1 activation, thereby reducing the efficiency of bacterial entry into the host. 
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CHAPTER 7 – Publications 
 
 
The following papers have been published or are submitted for publication in support of this 
dissertation. 
 
7.1 Crucial roles of TNFΑIP8 protein in regulating apoptosis and Listeria infection. 
 
Thomas P. Porturas, Honghong Sun, George Buchlis, Yunwei Lou, Xiaohong Liang, Derek S. 
Johnson, Zhaojun Wang, Youhai H. Chen. Submitted to the Journal of Immunology. 
*This paper contains the majority of the work in Chapters 3 and 5 of this dissertation 
 
Abstract 
 
TNFα-induced protein 8 (TNFAIP8 or TIPE) is a newly described regulator of cancer and 
infection. However, its precise roles and mechanisms of actions are not well understood. We 
report here that TNFAIP8 regulates Listeria monocytogenes infection by controlling pathogen 
invasion and host cell apoptosis in a RAC1 GTPase-dependent manner. TNFAIP8 knockout mice 
were found to be resistant to lethal L. monocytogenes infection and had reduced bacterial load in 
the liver and spleen. TNFAIP8-knockdown in murine liver HEPA1-6 cells increased apoptosis, 
reduced bacterial invasion into cells, and resulted in dysregulated RAC1 activation. TNFAIP8 
could translocate to plasma membrane and preferentially associate with activated GTP-RAC1. 
The combined effect of reduced bacterial invasion and increased sensitivity to TNFa-induced 
clearance likely protected the TNFAIP8 knockout mice from lethal listeriosis. Thus, by controlling 
bacterial invasion and the death of infected cells through RAC1, TNFAIP8 regulates the 
pathogenesis of L. monocytogenes infection. 
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7.2 Exacerbated Experimental Colitis In TNFAIP8-deficient Mice. 
 
Honghong Sun, Yunwei Lou, Thomas Porturas, Samantha Morrissey, George Luo, Ji Qi, 
Qingguo Ruan, and Youhai H. Chen. Submitted to the Journal of Immunology. 
*This paper contains the majority of the work in Chapter 4 of this dissertation 
 
Abstract 
 
The TNF-α-induced protein 8 (TNFAIP8 or TIPE) is a risk factor for lymphoma genesis and 
bacterial infection, and is upregulated in a number of human cancers. However, its physiological 
and pathological functions are unclear. Here we report the generation of TIPE-deficient mice and 
describe their increased responsiveness to colonic inflammation. TIPE-deficient mice were 
generated by germ line gene targeting and were born without noticeable developmental 
abnormalities. Their major organs including lymphoid organs and intestines were macroscopically 
and microscopically normal. However, after drinking dextran sodium sulfate-containing water, 
TIPE-deficient mice developed more severe colitis than wild type mice, as demonstrated by 
decreased survival rates, increased body weight loss, and enhanced leukocyte infiltration, 
bacterial invasion, and inflammatory cytokine production in the colon. Bone marrow chimeric 
experiments revealed that TIPE deficiency in non-hematopoietic cells was responsible for the 
exacerbated colitis in TIPE-deficient mice. Consistent with this result, TIPE-deficient intestinal 
epithelial cells had increased rate of cell death and decreased rate of proliferation as compared to 
wild type controls. Taken together, these findings indicate that TIPE plays an important role in 
maintaining colon homeostasis and in protecting against colitis. 
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7.3 Critical roles of TIPE2 protein in murine experimental colitis. 
 
Yunwei Lou, Honghong Sun, Samantha Morrissey, Thomas Porturas, Suxia Liu, Xianxin Hua, 
and Youhai H. Chen. (2014). J Immunol 193(3), 1064-1070. 
 
Abstract 
 
Both commensal bacteria and infiltrating inflammatory cells play essential roles in the 
pathogenesis of inflammatory bowel disease. The molecular mechanisms whereby these 
pathogenic factors are controlled during the disease are not fully understood. We report here that 
a member of the TNFAIP8 (tumor necrosis factor-a-induced protein 8) family called TIPE2 
(TNFAIP8-like 2, or TNFAIP8L2) plays a crucial role in regulating commensal bacteria 
dissemination and inflammatory cell function in experimental colitis induced by dextran sodium 
sulfate (DSS). Following DSS treatment, TIPE2-deficient mice, or chimeric mice that are deficient 
in TIPE2 only in their hematopoietic cells, lost much less body weight and survived longer than 
wild type controls. Consistent with this clinical observation, TIPE2-deficient mice exhibited 
significantly less severe colitis and colonic damage. This was associated with a marked reduction 
in the colonic expression of inflammatory cytokines such as TNF-α, IL-6, and IL-12. Importantly, 
the ameliorated DSS-induced colitis in TIPE2-/- mice was also associated with reduced local 
dissemination of commensal bacteria and the systemic inflammatory response. Combined with 
our previous report that TIPE2 is a negative regulator of anti-bacterial immunity, these results 
indicate that TIPE2 promotes colitis by inhibiting mucosal immunity to commensal bacteria.  
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